CHARLES CLEELAND

TitleProfessor
InstitutionMD Anderson
DepartmentSymptom Research CAO
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mendoza T, Sheshadri A, Altan M, Hess K, George G, Stephen B, Castillo L, Rodriguez E, Gong J, Peterson C, Rodon Ahnert J, Fu S, Piha-Paul SA, Pant S, Dumbrava E, Yap TA, Janku F, Tsimberidou AM, Subbiah V, Karp DD, Zarifa A, McQuinn LM, Cleeland C, Hong DS, Naing A. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. J Immunother Cancer. 2020 Oct; 8(2). PMID: 33097611.
      Citations:    Fields:    
    2. Tanaka S, Sato I, Takahashi M, Armstrong TS, Cleeland CS, Mendoza TR, Mukasa A, Takayanagi S, Narita Y, Kamibeppu K, Saito N. Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module. Jpn J Clin Oncol. 2020 Jul 09; 50(7):787-793. PMID: 32280995.
      Citations:    Fields:    Translation:Humans
    3. Whisenant MS, Williams LA, Garcia Gonzalez A, Mendoza T, Shi Q, Cleeland C, Zhang J, Heymach J, Simon G. What Do Patients With Non-Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer. JCO Oncol Pract. 2020 Oct; 16(10):e1151-e1160. PMID: 32539654.
      Citations:    
    4. Kamal M, Wang XS, Shi Q, Zyczynski TM, Davis C, Williams LA, Lin HK, Garcia-Gonzalez A, Cleeland CS, Orlowski R. Symptom burden and its functional impact in patients with "symptomatic" relapsed or refractory multiple myeloma. Support Care Cancer. 2021 Jan; 29(1):467-475. PMID: 32390093.
      Citations:    Fields:    
    5. Shi Q, Lee JW, Wang XS, Fisch MJ, Chang VT, Wagner L, Cleeland CS. Testing Symptom Severity Thresholds and Potential Alerts for Clinical Intervention in Patients With Cancer Undergoing Chemotherapy. JCO Oncol Pract. 2020 Sep; 16(9):e893-e901. PMID: 32369412.
      Citations:    
    6. Stover AM, Urick BY, Deal AM, Teal R, Vu MB, Carda-Auten J, Jansen J, Chung AE, Bennett AV, Chiang A, Cleeland C, Deutsch Y, Tai E, Zylla D, Williams LA, Pitzen C, Snyder C, Reeve B, Smith T, McNiff K, Cella D, Neuss MN, Miller R, Atkinson TM, Spears PA, Smith ML, Geoghegan C, Basch EM. Performance Measures Based on How Adults With Cancer Feel and Function: Stakeholder Recommendations and Feasibility Testing in Six Cancer Centers. JCO Oncol Pract. 2020 03; 16(3):e234-e250. PMID: 32074014.
      Citations:    
    7. Mendoza TR, Williams LA, Shi Q, Wang XS, Bamidele O, Woodruff JF, Cleeland CS. The Treatment-induced Neuropathy Assessment Scale (TNAS): a psychometric update following qualitative enrichment. J Patient Rep Outcomes. 2020 Feb 19; 4(1):15. PMID: 32076879.
      Citations:    
    8. Coens C, Pe M, Dueck AC, Sloan J, Basch E, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Devlin N, Dorme L, Flechtner HH, Gotay C, Griebsch I, Groenvold M, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Musoro JZ, O'Connor D, Oliver K, Piault-Louis E, Piccart M, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJB, Velikova G, Bottomley A. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. Lancet Oncol. 2020 02; 21(2):e83-e96. PMID: 32007209.
      Citations: 3     Fields:    Translation:Humans
    9. Kamal M, Wang XS, Shi Q, Mendoza T, Garcia-Gonzalez A, Bokhari RH, Cleeland CS, Fogelman DR. A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer. J Pain Symptom Manage. 2020 05; 59(5):1052-1058.e1. PMID: 31982605.
      Citations:    Fields:    
    10. George GC, Mendoza TR, Iwuanyanwu EC, Manandhar M, Afshar SF, Piha-Paul SA, Tsimberidou A, Naing A, Cleeland CS, Hong DS. Factors affecting symptom presentation in an early-phase clinical trials clinic patient population. Invest New Drugs. 2020 Aug; 38(4):1166-1174. PMID: 31761957.
      Citations:    Fields:    
    11. Suleiman K, Al Kalaldeh M, AbuSharour L, Yates B, Berger A, Mendoza T, Malak M, Salameh AB, Cleeland C, Menshawi A. Validation study of the Arabic version of the Brief Fatigue Inventory (BFI-A). East Mediterr Health J. 2019 Nov 25; 25(11):784-790. PMID: 31782514.
      Citations:    Fields:    Translation:Humans
    12. Wang XS, Shi Q, Mendoza T, Lin S, Chang JY, Bokhari RH, Lin HK, Garcia-Gonzalez A, Kamal M, Cleeland CS, Liao Z. Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial. Int J Radiat Oncol Biol Phys. 2020 01 01; 106(1):100-107. PMID: 31627177.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    13. Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E, Greenlee H, Hansen E, Kamal AH, Kamdar MM, LeGrand S, Mackey S, McDowell MR, Moryl N, Nabell LM, Nesbit S, O'Connor N, Rabow MW, Rickerson E, Shatsky R, Sindt J, Urba SG, Youngwerth JM, Hammond LJ, Gurski LA. Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 08 01; 17(8):977-1007. PMID: 31390582.
      Citations: 7     Fields:    Translation:Humans
    14. Hoang JM, Upadhyay N, Dike DN, Lee J, Johnson ML, Cleeland CS, Mendoza T, Chen H, Trivedi MV. Patient-reported outcomes in light of supportive medications in treatment-naïve lung cancer patients. Support Care Cancer. 2020 Apr; 28(4):1809-1816. PMID: 31338641.
      Citations:    Fields:    Translation:Humans
    15. Wang XS, Shi Q, Bhadkamkar NA, Cleeland CS, Garcia-Gonzalez A, Aguilar JR, Heijnen C, Eng C. Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial. J Pain Symptom Manage. 2019 10; 58(4):662-671. PMID: 31254639.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    16. Mendoza TR, Williams LA, Keating KN, Siegel J, Elbi C, Nowak AK, Hassan R, Cuffel B, Cleeland CS. Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM). J Patient Rep Outcomes. 2019 Jun 17; 3(1):34. PMID: 31209661.
      Citations:    
    17. Shi Q, Mendoza TR, Cleeland CS. Interpreting Patient-reported Outcome Scores for Clinical Research and Practice: Definition, Determination, and Application of Cutpoints. Med Care. 2019 05; 57 Suppl 5 Suppl 1:S8-S12. PMID: 30985590.
      Citations: 2     Fields:    Translation:Humans
    18. Gunn GB, Mendoza TR, Garden AS, Wang XS, Shi Q, Morrison WH, Frank SJ, Phan J, Fuller CD, Chambers MS, Hanna EY, Lu C, Rosenthal DI, Cleeland CS. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer. 2020 Jan; 28(1):261-269. PMID: 31037378.
      Citations: 2     Fields:    Translation:Humans
    19. George GC, Barata PC, Campbell A, Chen A, Cortes JE, Hyman DM, Jones L, Karagiannis T, Klaar S, Le-Rademacher JG, LoRusso P, Mandrekar SJ, Merino DM, Minasian LM, Mitchell SA, Montez S, O'Connor DJ, Pettit S, Silk E, Sloan JA, Stewart M, Takimoto CH, Wong GY, Yap TA, Cleeland CS, Hong DS. Improving attribution of adverse events in oncology clinical trials. Cancer Treat Rev. 2019 Jun; 76:33-40. PMID: 31108240.
      Citations: 2     Fields:    Translation:Humans
    20. George GC, Iwuanyanwu EC, Buford AS, Piha-Paul SA, Subbiah V, Fu S, Karp DD, Pant S, Hinojosa CO, Hess KR, Cleeland CS, Bernstam EV, Meric-Bernstam F, Hong DS. Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational Study. J Med Internet Res. 2019 03 14; 21(3):e10348. PMID: 30869638.
      Citations: 1     Fields:    Translation:Humans
    21. Wang XS, Shi Q, Williams LA, Cleeland CS, Garcia-Gonzalez A, Chen TY, Shahid DR, Ramirez PT, Iniesta MD, Siverand AM, Meyer LA. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN). Gynecol Oncol. 2019 03; 152(3):492-500. PMID: 30876494.
      Citations:    Fields:    Translation:Humans
    22. Mendoza TR, Kehl KL, Bamidele O, Williams LA, Shi Q, Cleeland CS, Simon G. Assessment of baseline symptom burden in treatment-naïve patients with lung cancer: an observational study. Support Care Cancer. 2019 Sep; 27(9):3439-3447. PMID: 30661202.
      Citations: 3     Fields:    Translation:Humans
    23. George GC, Buford A, Hess K, Piha-Paul SA, Zinner R, Subbiah V, Hinojosa C, Cleeland CS, Meric-Bernstam F, Bernstam EV, Hong DS. Cancer-Related Internet Use and Online Social Networking Among Patients in an Early-Phase Clinical Trials Clinic at a Comprehensive Cancer Center. JCO Clin Cancer Inform. 2018 12; 2:1-14. PMID: 30652565.
      Citations: 1     Fields:    Translation:Humans
    24. Zulbaran-Rojas A, Lin HK, Shi Q, Williams LA, George B, Garcia-Manero G, Jabbour E, O'Brien S, Ravandi F, Wierda W, Estrov Z, Borthakur G, Kadia T, Cleeland C, Cortes JE, Kantarjian H. A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitors. Cancer Med. 2018 11; 7(11):5457-5469. PMID: 30318751.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    25. Williams LA, Whisenant MS, Mendoza TR, Haq S, Keating KN, Cuffel B, Cleeland CS. Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM). Qual Life Res. 2018 Dec; 27(12):3229-3241. PMID: 30187393.
      Citations: 2     Fields:    Translation:Humans
    26. Pe M, Dorme L, Coens C, Basch E, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dirven L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Griebsch I, Groenvold M, King M, Koller M, Malone DC, Martinelli F, Mitchell SA, Musoro JZ, Oliver K, Piault-Louis E, Piccart M, Pimentel FL, Quinten C, Reijneveld JC, Sloan J, Velikova G, Bottomley A. Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. Lancet Oncol. 2018 09; 19(9):e459-e469. PMID: 30191850.
      Citations: 5     Fields:    Translation:Humans
    27. Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Greimel E, Griebsch I, Groenvold M, Hamel JF, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Moinpour CM, Musoro JZ, O'Connor D, Oliver K, Piault-Louis E, Piccart M, Pimentel FL, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Sridhara R, Taphoorn MJB, Velikova G, Coens C. Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials. Clin Trials. 2018 12; 15(6):624-630. PMID: 30141714.
      Citations: 12     Fields:    Translation:Humans
    28. Williams LA, Garcia-Gonzalez A, Mendoza TR, Haq S, Cleeland CS. Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS). Support Care Cancer. 2019 Mar; 27(3):1021-1028. PMID: 30094731.
      Citations: 1     Fields:    Translation:Humans
    29. Raad S, Chaftari AM, Hachem RY, Shah P, Natividad E, Cleeland CS, Rosenblatt J. Removal and insertion of central venous catheters in cancer patients is associated with high symptom burden. Expert Rev Med Devices. 2018 Aug; 15(8):591-596. PMID: 30067125.
      Citations:    Fields:    Translation:Humans
    30. Schoen MW, Basch E, Hudson LL, Chung AE, Mendoza TR, Mitchell SA, St Germain D, Baumgartner P, Sit L, Rogak LJ, Shouery M, Shalley E, Reeve BB, Fawzy MR, Bhavsar NA, Cleeland C, Schrag D, Dueck AC, Abernethy AP. Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study. JMIR Hum Factors. 2018 Jul 16; 5(3):e10070. PMID: 30012546.
      Citations:    
    31. Leleu X, Masszi T, Bahlis NJ, Viterbo L, Baker B, Gimsing P, Maisnar V, Samoilova O, Rosiñol L, Langer C, Song K, Izumi T, Cleeland C, Berg D, Lin HM, Zhu Y, Skacel T, Moreau P, Richardson PG. Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma. Am J Hematol. 2018 May 04. PMID: 29726031.
      Citations: 4     Fields:    
    32. Yue J, Shi Q, Xu T, Jeter M, Chen TY, Komaki R, Gomez DR, Pan T, Cleeland CS, Liao Z, Wang XS. Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study. Qual Life Res. 2018 06; 27(6):1563-1570. PMID: 29549533.
      Citations: 1     Fields:    Translation:Humans
    33. Shah N, Shi Q, Giralt S, Williams L, Bashir Q, Qazilbash M, Champlin RE, Cleeland CS, Wang XS. Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma. Qual Life Res. 2018 Apr; 27(4):979-985. PMID: 29260444.
      Citations: 1     Fields:    Translation:Humans
    34. Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Brandon Gunn G. Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol. 2017 11 23; 12(1):186. PMID: 29169353.
      Citations:    Fields:    
    35. Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero MH, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O'Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value Health. 2018 06; 21(6):742-747. PMID: 29909880.
      Citations: 3     Fields:    Translation:Humans
    36. Mendoza TR, Dueck AC, Shi Q, Ma H, Zhang J, Qian Y, Cleeland CS. The contribution of pain in determining the health status of cancer patients with bone metastases: A secondary analysis of data from three Phase III registration trials. Eur J Pain. 2018 03; 22(3):565-571. PMID: 29082574.
      Citations: 1     Fields:    Translation:Humans
    37. Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Gunn GB. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol. 2017 Sep 09; 12(1):150. PMID: 28888224.
      Citations: 5     Fields:    Translation:Humans
    38. Shi Q, Mendoza TR, Dueck AC, Ma H, Zhang J, Qian Y, Bhowmik D, Cleeland CS. Determination of mild, moderate, and severe pain interference in patients with cancer. Pain. 2017 06; 158(6):1108-1112. PMID: 28267060.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    39. Majedi H, Dehghani SS, Soleyman-Jahi S, Emami Meibodi SA, Mireskandari SM, Hajiaghababaei M, Tafakhori A, Mendoza TR, Cleeland CS. Validation of the Persian Version of the Brief Pain Inventory (BPI-P) in Chronic Pain Patients. J Pain Symptom Manage. 2017 07; 54(1):132-138.e2. PMID: 28479416.
      Citations: 7     Fields:    Translation:Humans
    40. Feng Y, Herdman M, van Nooten F, Cleeland C, Parkin D, Ikeda S, Igarashi A, Devlin NJ. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D. Qual Life Res. 2017 08; 26(8):2067-2078. PMID: 28343350.
      Citations: 3     Fields:    Translation:Humans
    41. Baljevic M, Zaman S, Baladandayuthapani V, Lin YH, de Partovi CM, Berkova Z, Amini B, Thomas SK, Shah JJ, Weber DM, Fu M, Cleeland CS, Wang XS, Stellrecht CM, Davis RE, Gandhi V, Orlowski RZ. Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma. Ann Hematol. 2017 Jun; 96(6):977-985. PMID: 28337527.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    42. Mendoza TR, Dueck AC, Bennett AV, Mitchell SA, Reeve BB, Atkinson TM, Li Y, Castro KM, Denicoff A, Rogak LJ, Piekarz RL, Cleeland CS, Sloan JA, Schrag D, Basch E. Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE. Clin Trials. 2017 Jun; 14(3):255-263. PMID: 28545337.
      Citations: 16     Fields:    Translation:Humans
    43. Fogelman DR, Morris J, Xiao L, Hassan M, Vadhan S, Overman M, Javle S, Shroff R, Varadhachary G, Wolff R, Vence L, Maitra A, Cleeland C, Wang XS. A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients. Support Care Cancer. 2017 06; 25(6):1809-1817. PMID: 28111717.
      Citations: 7     Fields:    Translation:Humans
    44. Jain P, Keating M, Renner S, Cleeland C, Xuelin H, Gonzalez GN, Harris D, Li P, Liu Z, Veletic I, Rozovski U, Jain N, Thompson P, Bose P, DiNardo C, Ferrajoli A, O'Brien S, Burger J, Wierda W, Verstovsek S, Kantarjian H, Estrov Z. Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial. Lancet Haematol. 2017 Feb; 4(2):e67-e74. PMID: 28089238.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    45. Celik EC, Yalcinkaya EY, Atamaz F, Karatas M, Ones K, Sezer T, Eren I, Paker N, Gning I, Mendoza T, Cleeland CS. Validity and reliability of a Turkish Brief Pain Inventory Short Form when used to evaluate musculoskeletal pain. J Back Musculoskelet Rehabil. 2017; 30(2):229-233. PMID: 27472857.
      Citations: 2     Fields:    Translation:Humans
    46. Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Greimel E, Griebsch I, Groenvold M, Hamel JF, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Moinpour CM, Musoro J, O'Connor D, Oliver K, Piault-Louis E, Piccart M, Pimentel FL, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJB, Velikova G, Coens C. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Lancet Oncol. 2016 Nov; 17(11):e510-e514. PMID: 27769798.
      Citations: 32     Fields:    Translation:Humans
    47. Paramita N, Nusdwinuringtyas N, Nuhonni SA, Atmakusuma TD, Ismail RI, Mendoza TR, Cleeland CS. Validity and Reliability of the Indonesian Version of the Brief Fatigue Inventory in Cancer Patients. J Pain Symptom Manage. 2016 11; 52(5):744-751. PMID: 27660081.
      Citations: 1     Fields:    Translation:Humans
    48. Shi Q, Mendoza TR, Wang XS, Cleeland CS. Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancer. Eur J Cancer. 2016 11; 67:83-90. PMID: 27620946.
      Citations: 4     Fields:    Translation:Humans
    49. Murdock KW, Wang XS, Shi Q, Cleeland CS, Fagundes CP, Vernon SD. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Qual Life Res. 2017 04; 26(4):913-921. PMID: 27600520.
      Citations: 9     Fields:    Translation:Humans
    50. Shi Q, Wang XS, Vaporciyan AA, Rice DC, Popat KU, Cleeland CS. Patient-Reported Symptom Interference as a Measure of Postsurgery Functional Recovery in Lung Cancer. J Pain Symptom Manage. 2016 12; 52(6):822-831. PMID: 27521528.
      Citations: 8     Fields:    Translation:Humans
    51. George GC, Iwuanyanwu EC, Anderson KO, Yusuf A, Zinner RG, Piha-Paul SA, Tsimberidou AM, Naing A, Fu S, Janku F, Subbiah V, Cleeland CS, Mendoza TR, Hong DS. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials. Cancer. 2016 Nov 15; 122(21):3401-3409. PMID: 27412379.
      Citations: 6     Fields:    Translation:Humans
    52. Pettit SD, Lipshultz SE, Cleeland CS, Roberts S, Davis M, Berridge BR, Kirch RA. Enhancing quality of life as a goal for anticancer therapeutics. Sci Transl Med. 2016 06 22; 8(344):344ed9. PMID: 27334258.
      Citations: 3     Fields:    Translation:Humans
    53. Gunn GB, Atalar B, Mendoza TR, Cleeland CS, Selek U, Özyar E, Rosenthal DI. Linguistic Validation of the Turkish Version of the M.D. Anderson Symptom Inventory - Head and Neck Cancer Module. Balkan Med J. 2016 May; 33(3):339-43. PMID: 27308079.
      Citations:    Fields:    
    54. Cleeland C, von Moos R, Walker MS, Wang Y, Gao J, Chavez-MacGregor M, Liede A, Arellano J, Balakumaran A, Qian Y. Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer. Support Care Cancer. 2016 08; 24(8):3557-65. PMID: 27022965.
      Citations: 5     Fields:    Translation:Humans
    55. Sio TT, Lin HK, Shi Q, Gunn GB, Cleeland CS, Lee JJ, Hernandez M, Blanchard P, Thaker NG, Phan J, Rosenthal DI, Garden AS, Morrison WH, Fuller CD, Mendoza TR, Mohan R, Wang XS, Frank SJ. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1107-14. PMID: 27354125.
      Citations: 16     Fields:    Translation:Humans
    56. Sánchez D, Chala A, Alvarez A, Payan C, Mendoza T, Cleeland C, Sanabria A. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language. J Pain Symptom Manage. 2016 06; 51(6):1055-61. PMID: 26899822.
      Citations: 1     Fields:    Translation:Humans
    57. Wang XS, Shi Q, Dougherty PM, Eng C, Mendoza TR, Williams LA, Fogelman DR, Cleeland CS. Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer. Oncology. 2016; 90(3):127-35. PMID: 26882477.
      Citations: 9     Fields:    Translation:Humans
    58. Wang XS, Shi Q, Williams LA, Komaki R, Gomez DR, Lin SH, Chang JY, O'Reilly MS, Bokhari RH, Cox JD, Mohan R, Cleeland CS, Liao Z. Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy. J Pain Symptom Manage. 2016 05; 51(5):832-8. PMID: 26891607.
      Citations: 12     Fields:    Translation:Humans
    59. Shah JJ, Feng L, Thomas SK, Berkova Z, Weber DM, Wang M, Qazilbash MH, Champlin RE, Mendoza TR, Cleeland C, Orlowski RZ. Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial. Blood Cancer J. 2016 Feb 12; 6:e396. PMID: 26871714.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    60. Zikos E, Coens C, Quinten C, Ediebah DE, Martinelli F, Ghislain I, King MT, Gotay C, Ringash J, Velikova G, Reeve BB, Greimel E, Cleeland CS, Flechtner H, Taphoorn MJ, Weis J, Schmucker-von Koch J, Sprangers MA, Bottomley A. The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative. J Natl Cancer Inst. 2016 May; 108(5). PMID: 26714759.
      Citations: 7     Fields:    Translation:Humans
    61. Tevaarwerk AJ, Lee JW, Terhaar A, Sesto ME, Smith ML, Cleeland CS, Fisch MJ. Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study. Cancer. 2016 02 01; 122(3):438-46. PMID: 26687819.
      Citations: 5     Fields:    Translation:Humans
    62. Chu SH, Lee YJ, Lee YJ, Cleeland CS. [Properties of the Measures to Assess Oxaliplatin-induced Peripheral Neuropathy: A Literature Review]. J Korean Acad Nurs. 2015 Dec; 45(6):783-801. PMID: 26805492.
      Citations: 1     Fields:    Translation:Humans
    63. Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD, Gillis TA, Harness JK, Siegel RD, Paul DB, Cleeland CS, Schrag D, Sloan JA, Abernethy AP, Bruner DW, Minasian LM, Basch E. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015 Nov; 1(8):1051-9. PMID: 26270597.
      Citations: 106     Fields:    Translation:HumansPHPublic Health
    64. Day RW, Cleeland CS, Wang XS, Fielder S, Calhoun J, Conrad C, Vauthey JN, Gottumukkala V, Aloia TA. Patient-Reported Outcomes Accurately Measure the Value of an Enhanced Recovery Program in Liver Surgery. J Am Coll Surg. 2015 Dec; 221(6):1023-30.e1-2. PMID: 26611799.
      Citations: 18     Fields:    Translation:Humans
    65. Gunn GB, Hansen CC, Garden AS, Fuller CD, Mohamed AS, Morrison WH, Frank SJ, Beadle BM, Phan J, Chronowski GM, Sturgis EM, Lewis CM, Lu C, Hutcheson KA, Mendoza TR, Cleeland CS, Rosenthal DI. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol. 2015 Oct; 117(1):132-8. PMID: 26403258.
      Citations: 8     Fields:    Translation:Humans
    66. von Moos R, Body JJ, Egerdie B, Stopeck A, Brown J, Fallowfield L, Patrick DL, Cleeland C, Damyanov D, Palazzo FS, Marx G, Zhou Y, Braun A, Balakumaran A, Qian Y. Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Support Care Cancer. 2016 Mar; 24(3):1327-37. PMID: 26329397.
      Citations: 16     Fields:    Translation:Humans
    67. Dadu R, Hu MI, Cleeland C, Busaidy NL, Habra M, Waguespack SG, Sherman SI, Ying A, Fox P, Cabanillas ME. Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer-Related Diarrhea and Its Effects on Quality of Life: A Pilot Study. Thyroid. 2015 Oct; 25(10):1085-90. PMID: 26200040.
      Citations: 6     Fields:    Translation:Humans
    68. Shah N, Shi Q, Williams LA, Mendoza TR, Wang XS, Reuben JM, Dougherty PM, Bashir Q, Qazilbash MH, Champlin RE, Cleeland CS, Giralt SA. Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis. Biol Blood Marrow Transplant. 2016 Feb; 22(2):226-231. PMID: 26253006.
      Citations: 4     Fields:    Translation:HumansCells
    69. Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C. Cancer-Related Fatigue, Version 2.2015. J Natl Compr Canc Netw. 2015 Aug; 13(8):1012-39. PMID: 26285247.
      Citations: 83     Fields:    Translation:Humans
    70. Mendoza TR, Wang XS, Williams LA, Shi Q, Vichaya EG, Dougherty PM, Thomas SK, Yucel E, Bastida CC, Woodruff JF, Cleeland CS. Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale. J Pain. 2015 Oct; 16(10):1032-43. PMID: 26210041.
      Citations: 5     Fields:    Translation:Humans
    71. Fagundes CP, Shi Q, Vaporciyan AA, Rice DC, Popat KU, Cleeland CS, Wang XS. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg. 2015 Sep; 150(3):613-9.e2. PMID: 26088408.
      Citations: 17     Fields:    Translation:Humans
    72. Cleeland CS, Rose SL. Symptom management of gynecologic cancers: refocusing on the forest. Gynecol Oncol. 2015 Mar; 136(3):413-4. PMID: 25752571.
      Citations:    Fields:    Translation:Humans
    73. Anderson KO, Palos GR, Mendoza TR, Cleeland CS, Liao KP, Fisch MJ, Garcia-Gonzalez A, Rieber AG, Nazario LA, Valero V, Hahn KM, Person CL, Payne R. Automated pain intervention for underserved minority women with breast cancer. Cancer. 2015 Jun 01; 121(11):1882-90. PMID: 25711974.
      Citations: 6     Fields:    Translation:Humans
    74. Patrick DL, Cleeland CS, von Moos R, Fallowfield L, Wei R, Öhrling K, Qian Y. Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents. Support Care Cancer. 2015 Apr; 23(4):1157-68. PMID: 25533578.
      Citations: 7     Fields:    Translation:Humans
    75. Shi Q, Wang XS, Li G, Shah ND, Orlowski RZ, Williams LA, Mendoza TR, Cleeland CS. Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis. Cancer. 2015 Apr 01; 121(7):1138-46. PMID: 25469832.
      Citations: 10     Fields:    Translation:Humans
    76. Wang XS, Shi Q, Williams LA, Shah ND, Mendoza TR, Cohen EN, Reuben JM, Cleeland CS, Orlowski RZ. Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma. Leuk Lymphoma. 2015 May; 56(5):1335-41. PMID: 25248883.
      Citations: 5     Fields:    Translation:Humans
    77. Hanna EY, Mendoza TR, Rosenthal DI, Gunn GB, Sehra P, Yucel E, Cleeland CS. The symptom burden of treatment-naive patients with head and neck cancer. Cancer. 2015 Mar 01; 121(5):766-73. PMID: 25369213.
      Citations: 10     Fields:    Translation:Humans
    78. Fagundes C, Jones D, Vichaya E, Lu C, Cleeland CS. Socioeconomic status is associated with depressive severity among patients with advanced non-small-cell lung cancer: treatment setting and minority status do not make a difference. J Thorac Oncol. 2014 Oct; 9(10):1459-63. PMID: 25170640.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    79. Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014 Sep; 106(9). PMID: 25265940.
      Citations: 150     Fields:    Translation:Humans
    80. Chu SH, Lee YJ, Lee ES, Geng Y, Wang XS, Cleeland CS. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review. Support Care Cancer. 2015 Feb; 23(2):513-24. PMID: 25256375.
      Citations: 8     Fields:    Translation:Humans
    81. Cleeland CS, Mayer M, Dreyer NA, Yim YM, Yu E, Su Z, Mun Y, Sloan JA, Kaufman PA. Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study. Breast. 2014 Dec; 23(6):763-9. PMID: 25193423.
      Citations: 11     Fields:    Translation:Humans
    82. de Carvalho Barbosa M, Kosturakis AK, Eng C, Wendelschafer-Crabb G, Kennedy WR, Simone DA, Wang XS, Cleeland CS, Dougherty PM. A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy. Cancer Res. 2014 Nov 01; 74(21):5955-62. PMID: 25183707.
      Citations: 16     Fields:    Translation:Humans
    83. Kosturakis AK, He Z, Li Y, Boyette-Davis JA, Shah N, Thomas SK, Zhang H, Vichaya EG, Wang XS, Wendelschafer-Crabb G, Kennedy WR, Simone DA, Cleeland CS, Dougherty PM. Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density. J Clin Oncol. 2014 Oct 01; 32(28):3156-62. PMID: 25154818.
      Citations: 13     Fields:    Translation:Humans
    84. Sheu T, Fuller CD, Mendoza TR, Garden AS, Morrison WH, Beadle BM, Phan J, Frank SJ, Hanna EY, Lu C, Cleeland CS, Rosenthal DI, Gunn GB. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):619-26. PMID: 25104816.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    85. Mao-Ying QL, Kavelaars A, Krukowski K, Huo XJ, Zhou W, Price TJ, Cleeland C, Heijnen CJ. The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model. PLoS One. 2014; 9(6):e100701. PMID: 24955774.
      Citations: 58     Fields:    Translation:AnimalsCells
    86. Cleeland CS, Williams LA. Symptom burden in hematologic malignancies. Blood. 2014 Jun 12; 123(24):3686-7. PMID: 24926067.
      Citations: 1     Fields:    Translation:Humans
    87. Schmidt H, Cleeland CS, Bauer A, Landenberger M, Jahn P. Symptom burden of cancer patients: validation of the German M. D. Anderson Symptom Inventory: a cross-sectional multicenter study. J Pain Symptom Manage. 2015 Jan; 49(1):117-25. PMID: 24858739.
      Citations: 2     Fields:    Translation:Humans
    88. Martin-Broto J, Cleeland CS, Glare PA, Engellau J, Skubitz KM, Blum RH, Ganjoo KN, Staddon A, Dominkus M, Feng A, Qian Y, Braun A, Jacobs I, Chung K, Atchison C. Effects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II study. Acta Oncol. 2014 Sep; 53(9):1173-9. PMID: 24834795.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    89. Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014 Jul 01; 120(13):1975-84. PMID: 24711162.
      Citations: 25     Fields:    Translation:Humans
    90. Wang XS, Zhao F, Fisch MJ, O'Mara AM, Cella D, Mendoza TR, Cleeland CS. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014 Feb 01; 120(3):425-32. PMID: 24436136.
      Citations: 62     Fields:    Translation:Humans
    91. Wang XS, Shi Q, Shah ND, Heijnen CJ, Cohen EN, Reuben JM, Orlowski RZ, Qazilbash MH, Johnson VE, Williams LA, Mendoza TR, Cleeland CS. Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. Clin Cancer Res. 2014 Mar 01; 20(5):1366-74. PMID: 24423611.
      Citations: 22     Fields:    Translation:Humans
    92. Escalante CP, Meyers C, Reuben JM, Wang X, Qiao W, Manzullo E, Alvarez RH, Morrow PK, Gonzalez-Angulo AM, Wang XS, Mendoza T, Liu W, Holmes H, Hwang J, Pisters K, Overman M, Cleeland C. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J. 2014 Jan-Feb; 20(1):8-14. PMID: 24445757.
      Citations: 11     Fields:    Translation:Humans
    93. Zhao F, Chang VT, Cleeland C, Cleary JF, Mitchell EP, Wagner LI, Fisch MJ. Determinants of pain severity changes in ambulatory patients with cancer: an analysis from Eastern Cooperative Oncology Group trial E2Z02. J Clin Oncol. 2014 Feb 01; 32(4):312-9. PMID: 24366929.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    94. Banerjee AK, Okun S, Edwards IR, Wicks P, Smith MY, Mayall SJ, Flamion B, Cleeland C, Basch E. Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance. Drug Saf. 2013 Dec; 36(12):1129-49. PMID: 24092596.
      Citations: 24     Fields:    Translation:Humans
    95. Williams LA, Yucel E, Cortes JE, Cleeland CS. Measuring symptoms as a critical component of drug development and evaluation in hematological diseases. Clin Investig (Lond). 2013 Dec 01; 3(12):1127-1138. PMID: 24910769.
      Citations:    
    96. Jones D, Vichaya EG, Cleeland CS, Cohen L, Thekdi SM, Wang XS, Fisch MJ. Screening for depressed mood in patients with cancer using the MD Anderson Symptom Inventory: investigation of a practical approach for the oncologist. J Oncol Pract. 2014 Mar; 10(2):e95-102. PMID: 24281151.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    97. Fisch MJ, Zhao F, O'Mara AM, Wang XS, Cella D, Cleeland CS. Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors. Cancer. 2014 Feb 01; 120(3):442-50. PMID: 24151111.
      Citations: 7     Fields:    Translation:Humans
    98. Jones D, Zhao F, Fisch MJ, Wagner LI, Patrick-Miller LJ, Cleeland CS, Mendoza TR. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group. Clin Genitourin Cancer. 2014 Feb; 12(1):41-9. PMID: 24126238.
      Citations: 7     Fields:    Translation:Humans
    99. Basch E, Autio K, Ryan CJ, Mulders P, Shore N, Kheoh T, Fizazi K, Logothetis CJ, Rathkopf D, Smith MR, Mainwaring PN, Hao Y, Griffin T, Li S, Meyers ML, Molina A, Cleeland C. Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial. Lancet Oncol. 2013 Nov; 14(12):1193-9. PMID: 24075621.
      Citations: 44     Fields:    Translation:HumansCTClinical Trials
    100. Cleeland CS, Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, Weiss M, Mendoza TR, Lee JW, Fisch MJ. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer. 2013 Dec 15; 119(24):4333-40. PMID: 24114037.
      Citations: 58     Fields:    Translation:Humans
    101. Jones D, Vichaya EG, Wang XS, Sailors MH, Cleeland CS, Wefel JS. Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer. 2013 Dec 01; 119(23):4188-95. PMID: 24105672.
      Citations: 12     Fields:    Translation:Humans
    102. Cleeland CS. Mechanisms of treatment-related symptoms in cancer patients. EJC Suppl. 2013 Sep; 11(2):301-2. PMID: 26217153.
      Citations:    
    103. von Moos R, Body JJ, Egerdie B, Stopeck A, Brown JE, Damyanov D, Fallowfield LJ, Marx G, Cleeland CS, Patrick DL, Palazzo FG, Qian Y, Braun A, Chung K. Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer. 2013 Dec; 21(12):3497-507. PMID: 23975226.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    104. Swarm RA, Abernethy AP, Anghelescu DL, Benedetti C, Buga S, Cleeland C, Deleon-Casasola OA, Eilers JG, Ferrell B, Green M, Janjan NA, Kamdar MM, Levy MH, Lynch M, McDowell RM, Moryl N, Nesbit SA, Paice JA, Rabow MW, Syrjala KL, Urba SG, Weinstein SM, Dwyer M, Kumar R. Adult cancer pain. J Natl Compr Canc Netw. 2013 Aug; 11(8):992-1022. PMID: 23946177.
      Citations: 27     Fields:    Translation:Humans
    105. Mendoza TR, Zhao F, Cleeland CS, Wagner LI, Patrick-Miller LJ, Fisch MJ. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group. Clin Breast Cancer. 2013 Oct; 13(5):325-34. PMID: 23816985.
      Citations: 5     Fields:    Translation:Humans
    106. Williams LA, Garcia Gonzalez AG, Ault P, Mendoza TR, Sailors ML, Williams JL, Huang F, Nazha A, Kantarjian HM, Cleeland CS, Cortes JE. Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood. 2013 Aug 01; 122(5):641-7. PMID: 23777764.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    107. Sailors MH, Bodurka DC, Gning I, Ramondetta LM, Williams LA, Mendoza TR, Agarwal S, Sun CC, Cleeland CS. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol. 2013 Aug; 130(2):323-8. PMID: 23685012.
      Citations: 8     Fields:    Translation:Humans
    108. Williams LA, Agarwal S, Bodurka DC, Saleeba AK, Sun CC, Cleeland CS. Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer. J Pain Symptom Manage. 2013 Dec; 46(6):837-45. PMID: 23615044.
      Citations: 12     Fields:    Translation:Humans
    109. Cohen MZ, Rozmus CL, Mendoza TR, Padhye NS, Neumann J, Gning I, Aleman A, Giralt S, Cleeland CS. Authors' reply to Tendas et al. J Pain Symptom Manage. 2013 Apr; 45(4):e3-4. PMID: 23544910.
      Citations:    Fields:    Translation:Humans
    110. Vichaya EG, Wang XS, Boyette-Davis JA, Mendoza TR, He Z, Thomas SK, Shah N, Williams LA, Cleeland CS, Dougherty PM. Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy. Cancer Chemother Pharmacol. 2013 Jun; 71(6):1531-40. PMID: 23543296.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    111. Shi Q, Mendoza TR, Gunn GB, Wang XS, Rosenthal DI, Cleeland CS. Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res. 2013 Nov; 22(9):2331-9. PMID: 23475689.
      Citations: 13     Fields:    Translation:Humans
    112. Shi Q, Giordano SH, Lu H, Saleeba AK, Malveaux D, Cleeland CS. Anastrozole-associated joint pain and other symptoms in patients with breast cancer. J Pain. 2013 Mar; 14(3):290-6. PMID: 23452648.
      Citations: 6     Fields:    Translation:Humans
    113. Jones D, Vichaya EG, Wang XS, Williams LA, Shah ND, Thomas SK, Johnson VE, Champlin RE, Cleeland CS, Mendoza TR. Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol. 2013 Feb 05; 6:13. PMID: 23384030.
      Citations: 14     Fields:    Translation:Humans
    114. Tevaarwerk AJ, Lee JW, Sesto ME, Buhr KA, Cleeland CS, Manola J, Wagner LI, Chang VT, Fisch MJ. Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study. J Cancer Surviv. 2013 Jun; 7(2):191-202. PMID: 23378060.
      Citations: 15     Fields:    Translation:Humans
    115. Barney BJ, Wang XS, Lu C, Liao Z, Johnson VE, Cleeland CS, Mendoza TR. Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer. Qual Life Res. 2013 Oct; 22(8):2143-50. PMID: 23371797.
      Citations: 4     Fields:    Translation:Humans
    116. Gunn GB, Mendoza TR, Fuller CD, Gning I, Frank SJ, Beadle BM, Hanna EY, Lu C, Cleeland CS, Rosenthal DI. High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study. Head Neck. 2013 Oct; 35(10):1490-8. PMID: 23169304.
      Citations: 17     Fields:    Translation:Humans
    117. Sternberg CN, Molina A, North S, Mainwaring P, Fizazi K, Hao Y, Rothman M, Gagnon DD, Kheoh T, Haqq CM, Cleeland C, de Bono JS, Scher HI. Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy. Ann Oncol. 2013 Apr; 24(4):1017-25. PMID: 23152362.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    118. Cleeland CS, Body JJ, Stopeck A, von Moos R, Fallowfield L, Mathias SD, Patrick DL, Clemons M, Tonkin K, Masuda N, Lipton A, de Boer R, Salvagni S, Oliveira CT, Qian Y, Jiang Q, Dansey R, Braun A, Chung K. Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer. 2013 Feb 15; 119(4):832-8. PMID: 22951813.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    119. Cleeland CS, Sloan JA, Cella D, Chen C, Dueck AC, Janjan NA, Liepa AM, Mallick R, O'Mara A, Pearson JD, Torigoe Y, Wang XS, Williams LA, Woodruff JF. Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force. Cancer. 2013 Jan 15; 119(2):411-20. PMID: 22930243.
      Citations: 23     Fields:    Translation:Humans
    120. Vadhan-Raj S, von Moos R, Fallowfield LJ, Patrick DL, Goldwasser F, Cleeland CS, Henry DH, Novello S, Hungria V, Qian Y, Feng A, Yeh H, Chung K. Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. Ann Oncol. 2012 Dec; 23(12):3045-3051. PMID: 22851406.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    121. Cleeland CS, Allen JD, Roberts SA, Brell JM, Giralt SA, Khakoo AY, Kirch RA, Kwitkowski VE, Liao Z, Skillings J. Reducing the toxicity of cancer therapy: recognizing needs, taking action. Nat Rev Clin Oncol. 2012 07 03; 9(8):471-8. PMID: 22751283.
      Citations: 25     Fields:    Translation:HumansPHPublic Health
    122. Cohen MZ, Rozmus CL, Mendoza TR, Padhye NS, Neumann J, Gning I, Aleman A, Giralt S, Cleeland CS. Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage. 2012 Aug; 44(2):168-80. PMID: 22699091.
      Citations: 24     Fields:    Translation:Humans
    123. Dantzer R, Meagher MW, Cleeland CS. Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol. 2012 May 29; 9(7):414-26. PMID: 22641361.
      Citations: 53     Fields:    Translation:HumansAnimals
    124. Rodgers GM, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, Coccia PF, Djulbegovic B, Gilreath JA, Kraut EH, Matulonis UA, Millenson MM, Reinke D, Rosenthal J, Schwartz RN, Soff G, Stein RS, Vlahovic G, Weir AB. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. 2012 May; 10(5):628-53. PMID: 22570293.
      Citations: 30     Fields:    Translation:Humans
    125. Mendoza TR, Koyyalagunta D, Burton AW, Thomas SK, Phan MH, Giralt SA, Shah JJ, Cleeland CS. Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty. J Pain. 2012 Jun; 13(6):564-70. PMID: 22543044.
      Citations: 10     Fields:    Translation:Humans
    126. Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D, Manola JB, Minasian LM, McCaskill-Stevens W, Mendoza TR, Cleeland CS. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012 Jun 01; 30(16):1980-8. PMID: 22508819.
      Citations: 85     Fields:    Translation:Humans
    127. Boyette-Davis JA, Eng C, Wang XS, Cleeland CS, Wendelschafer-Crabb G, Kennedy WR, Simone DA, Zhang H, Dougherty PM. Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy. Clin Cancer Res. 2012 Jun 01; 18(11):3180-7. PMID: 22496202.
      Citations: 14     Fields:    Translation:Humans
    128. Armstrong TS, Wefel JS, Gning I, Acquaye A, Vera-Bolanos E, Gilbert MR, Cleeland CS, Mendoza T. Congruence of primary brain tumor patient and caregiver symptom report. Cancer. 2012 Oct 15; 118(20):5026-37. PMID: 22415423.
      Citations: 9     Fields:    Translation:Humans
    129. Gunn GB, Koukourakis MI, Mendoza TR, Cleeland CS, Rosenthal DI. Linguistic validation of the Greek M.D. Anderson Symptom Inventory - Head and Neck Module. Forum Clin Oncol. 2012 Mar; 3(1):29-31. PMID: 23439668.
      Citations:    
    130. Wang XS, Rhines LD, Shiu AS, Yang JN, Selek U, Gning I, Liu P, Allen PK, Azeem SS, Brown PD, Sharp HJ, Weksberg DC, Cleeland CS, Chang EL. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol. 2012 Apr; 13(4):395-402. PMID: 22285199.
      Citations: 74     Fields:    Translation:HumansCTClinical Trials
    131. Wang XS, Williams LA, Krishnan S, Liao Z, Liu P, Mao L, Shi Q, Mobley GM, Woodruff JF, Cleeland CS. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun. 2012 Jul; 26(5):699-705. PMID: 22251605.
      Citations: 42     Fields:    Translation:Humans
    132. Quinten C, Maringwa J, Gotay CC, Martinelli F, Coens C, Reeve BB, Flechtner H, Greimel E, King M, Osoba D, Cleeland C, Ringash J, Schmucker-Von Koch J, Taphoorn MJ, Weis J, Bottomley A. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst. 2011 Dec 21; 103(24):1851-8. PMID: 22157640.
      Citations: 49     Fields:    Translation:Humans
    133. Cleeland CS. The integration of palliative care and oncology: the evidence. Oncology (Williston Park). 2011 Nov 30; 25(13):1266. PMID: 22272494.
      Citations:    Fields:    Translation:Humans
    134. Cleeland CS, O'Mara A, Zagari M, Baas C. Integrating pain metrics into oncology clinical trials. Clin Cancer Res. 2011 Nov 01; 17(21):6646-50. PMID: 22046026.
      Citations: 7     Fields:    Translation:Humans
    135. Martinelli F, Quinten C, Maringwa JT, Coens C, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Mendoza T, Osoba D, Reeve BB, Ringash J, Koch JS, Shi Q, Taphoorn MJ, Weis J, Bottomley A. Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct; 11(5):587-99. PMID: 21958103.
      Citations: 3     Fields:    Translation:Humans
    136. Cleeland CS, Mendoza TR, Wang XS, Woodruff JF, Palos GR, Richman SP, Nazario A, Lynch GR, Liao KP, Mobley GM, Lu C. Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. J Clin Oncol. 2011 Jul 20; 29(21):2859-65. PMID: 21690477.
      Citations: 16     Fields:    Translation:Humans
    137. Shi Q, Smith TG, Michonski JD, Stein KD, Kaw C, Cleeland CS. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer. 2011 Jun 15; 117(12):2779-90. PMID: 21495026.
      Citations: 60     Fields:    Translation:Humans
    138. Dworkin RH, Turk DC, Basch E, Berger A, Cleeland C, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Markman J, Porter L, Raja SN, Ross E, Todd K, Wallace M, Woolf CJ. Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy. Pain. 2011 Aug; 152(8):1705-8. PMID: 21396781.
      Citations: 11     Fields:    Translation:Humans
    139. Maringwa J, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Reeve BB, Gotay C, Greimel E, Flechtner H, Cleeland CS, Schmucker-Von Koch J, Weis J, Van Den Bent MJ, Stupp R, Taphoorn MJ, Bottomley A. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol. 2011 Sep; 22(9):2107-2112. PMID: 21324954.
      Citations: 39     Fields:    Translation:Humans
    140. Mendoza TR, Wang XS, Lu C, Palos GR, Liao Z, Mobley GM, Kapoor S, Cleeland CS. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist. 2011; 16(2):217-27. PMID: 21285393.
      Citations: 26     Fields:    Translation:Humans
    141. Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, Malveaux D, Shah PK, Gning I, Hofstetter WL, Putnam JB, Vaporciyan AA. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol. 2011 Mar 10; 29(8):994-1000. PMID: 21282546.
      Citations: 69     Fields:    Translation:Humans
    142. Armstrong TS, Vera-Bolanos E, Gning I, Acquaye A, Gilbert MR, Cleeland C, Mendoza T. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients. Cancer. 2011 Jul 15; 117(14):3222-8. PMID: 21264841.
      Citations: 18     Fields:    Translation:Humans
    143. Atkinson TM, Rosenfeld BD, Sit L, Mendoza TR, Fruscione M, Lavene D, Shaw M, Li Y, Hay J, Cleeland CS, Scher HI, Breitbart WS, Basch E. Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). J Pain Symptom Manage. 2011 Mar; 41(3):558-65. PMID: 21131166.
      Citations: 27     Fields:    Translation:Humans
    144. Mortimer JE, Barsevick AM, Bennett CL, Berger AM, Cleeland C, DeVader SR, Escalante C, Gilreath J, Hurria A, Mendoza TR, Rugo HS. Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Canc Netw. 2010 Dec; 8(12):1331-9. PMID: 21147900.
      Citations: 16     Fields:    Translation:Humans
    145. Abernethy AP, Aziz NM, Basch E, Bull J, Cleeland CS, Currow DC, Fairclough D, Hanson L, Hauser J, Ko D, Lloyd L, Morrison RS, Otis-Green S, Pantilat S, Portenoy RK, Ritchie C, Rocker G, Wheeler JL, Zafar SY, Kutner JS. A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med. 2010 Dec; 13(12):1407-13. PMID: 21105763.
      Citations: 30     Fields:    Translation:Humans
    146. Mendoza TR, Laudico AV, Wang XS, Guo H, Matsuda ML, Yosuico VD, Fragante EP, Cleeland CS. Assessment of fatigue in cancer patients and community dwellers: validation study of the Filipino version of the brief fatigue inventory. Oncology. 2010; 79(1-2):112-7. PMID: 21088437.
      Citations: 7     Fields:    Translation:Humans
    147. Palos GR, Mendoza TR, Liao KP, Anderson KO, Garcia-Gonzalez A, Hahn K, Nazario A, Ramondetta LM, Valero V, Lynch GR, Jibaja-Weiss ML, Cleeland CS. Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer. 2011 Mar 01; 117(5):1070-9. PMID: 20960510.
      Citations: 30     Fields:    Translation:Humans
    148. Maringwa JT, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, Taphoorn MJ, Reeve BB, Koch JS, Weis J, Smit EF, van Meerbeeck JP, Bottomley A. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer. 2011 Nov; 19(11):1753-60. PMID: 20886240.
      Citations: 39     Fields:    Translation:Humans
    149. Shi Q, Cleeland CS, Klepstad P, Miaskowski C, Pedersen NL. Biological pathways and genetic variables involved in pain. Qual Life Res. 2010 Dec; 19(10):1407-17. PMID: 20842532.
      Citations: 16     Fields:    Translation:HumansCells
    150. Swarm R, Abernethy AP, Anghelescu DL, Benedetti C, Blinderman CD, Boston B, Cleeland C, Coyle N, Deleon-Casasola OA, Eilers JG, Ferrell B, Janjan NA, Karver SB, Levy MH, Lynch M, Moryl N, Murphy BA, Nesbit SA, Oakes L, Obbens EA, Paice JA, Rabow MW, Syrjala KL, Urba S, Weinstein SM. Adult cancer pain. J Natl Compr Canc Netw. 2010 Sep; 8(9):1046-86. PMID: 20876544.
      Citations: 34     Fields:    Translation:Humans
    151. Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP, Jacobsen PB, Kaldor P, Ligibel JA, Murphy BA, O'Connor T, Pirl WF, Rodler E, Rugo HS, Thomas J, Wagner LI. NCCN Clinical Practice Guidelines Cancer-related fatigue. J Natl Compr Canc Netw. 2010 Aug; 8(8):904-31. PMID: 20870636.
      Citations: 55     Fields:    Translation:Humans
    152. Nejmi M, Wang XS, Mendoza TR, Gning I, Cleeland CS. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer. J Pain Symptom Manage. 2010 Jul; 40(1):75-86. PMID: 20619213.
      Citations: 8     Fields:    Translation:Humans
    153. Shi Q, Trask PC, Wang XS, Mendoza TR, Apraku WA, Malekifar M, Cleeland CS. Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms? J Pain Symptom Manage. 2010 Aug; 40(2):191-9. PMID: 20579835.
      Citations: 9     Fields:    Translation:Humans
    154. Cleeland CS, Sloan JA. Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards. J Pain Symptom Manage. 2010 Jun; 39(6):1077-85. PMID: 20538189.
      Citations: 35     Fields:    Translation:Humans
    155. Barsevick AM, Cleeland CS, Manning DC, O'Mara AM, Reeve BB, Scott JA, Sloan JA. ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage. 2010 Jun; 39(6):1086-99. PMID: 20538190.
      Citations: 33     Fields:    Translation:Humans
    156. Wang XS, Williams LA, Eng C, Mendoza TR, Shah NA, Kirkendoll KJ, Shah PK, Trask PC, Palos GR, Cleeland CS. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer. 2010 Apr 15; 116(8):2053-63. PMID: 20166216.
      Citations: 23     Fields:    Translation:Humans
    157. Guirimand F, Buyck JF, Lauwers-Allot E, Revnik J, Kerguen T, Aegerter P, Brasseur L, Cleeland CS. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2010 Apr; 39(4):721-33. PMID: 20413059.
      Citations: 7     Fields:    Translation:Humans
    158. Armstrong TS, Gning I, Mendoza TR, Vera-Bolanos E, Gilbert MR, Rhines LD, Weinberg JS, Sanchez-Williams G, Levin V, Burton AW, Cleeland C. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module. J Neurosurg Spine. 2010 Apr; 12(4):421-30. PMID: 20367379.
      Citations: 10     Fields:    Translation:Humans
    159. Wang XS, Shi Q, Williams LA, Mao L, Cleeland CS, Komaki RR, Mobley GM, Liao Z. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun. 2010 Aug; 24(6):968-74. PMID: 20353817.
      Citations: 74     Fields:    Translation:Humans
    160. Wang XS, Cleeland CS, Mendoza TR, Yun YH, Wang Y, Okuyama T, Johnson VE. Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst. 2010 May 19; 102(10):732-8. PMID: 20348233.
      Citations: 15     Fields:    Translation:Humans
    161. Ferreira KA, Teixeira MJ, Mendonza TR, Cleeland CS. Validation of brief pain inventory to Brazilian patients with pain. Support Care Cancer. 2011 Apr; 19(4):505-11. PMID: 20221641.
      Citations: 16     Fields:    Translation:Humans
    162. Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, Chappell A, Chartier K, Cleeland CS, Costello A, Cowan P, Dimitrova R, Ellenberg S, Farrar JT, French JA, Gilron I, Hertz S, Jadad AR, Jay GW, Kalliomäki J, Katz NP, Kerns RD, Manning DC, McDermott MP, McGrath PJ, Narayana A, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Reeve BB, Rhodes T, Sampaio C, Simpson DM, Stauffer JW, Stucki G, Tobias J, White RE, Witter J. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain. 2010 May; 149(2):177-93. PMID: 20207481.
      Citations: 80     Fields:    Translation:Humans
    163. Atkinson TM, Mendoza TR, Sit L, Passik S, Scher HI, Cleeland C, Basch E. The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations. Pain Med. 2010 Mar; 11(3):337-46. PMID: 20030743.
      Citations: 53     Fields:    Translation:Humans
    164. Cleeland CS, Farrar JT, Hausheer FH. Assessment of cancer-related neuropathy and neuropathic pain. Oncologist. 2010; 15 Suppl 2:13-8. PMID: 20489192.
      Citations: 18     Fields:    Translation:Humans
    165. Wang XS, Shi Q, Lu C, Basch EM, Johnson VE, Mendoza TR, Mobley GM, Cleeland CS. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer. 2010 Jan 01; 116(1):137-45. PMID: 19852033.
      Citations: 20     Fields:    Translation:Humans
    166. Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K, Bottomley A. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 2009 Sep; 10(9):865-71. PMID: 19695956.
      Citations: 130     Fields:    Translation:Humans
    167. Sprangers MA, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AP, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, Van Noorden CJ, Patrick DL, Pedersen NL, Ropka ME, Shi Q, Shinozaki G, Singh JA, Yang P, Zwinderman AH. The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet. 2009 Jun; 12(3):301-11. PMID: 19456223.
      Citations: 23     Fields:    Translation:Humans
    168. Bottomley A, Quinten C, Coens C, Martinelli F, Mauer M, Maringwa J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Osoba D, Taphoorn MJ, Reeve BB, Ringash J, Schmucker-Von Koch J, Weis J. Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiative. Eur J Cancer Care (Engl). 2009 Mar; 18(2):105-7. PMID: 19267723.
      Citations: 2     Fields:    Translation:Humans
    169. Park HC, Janjan NA, Mendoza TR, Lin EH, Vadhan-Raj S, Hundal M, Zhang Y, Delclos ME, Crane CH, Das P, Wang XS, Cleeland CS, Krishnan S. Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2009 Nov 01; 75(3):775-81. PMID: 19231100.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    170. Gning I, Trask PC, Mendoza TR, Harle MT, Gutierrez KA, Kitaka SA, Sherman SI, Cleeland CS. Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory. Oncology. 2009; 76(1):59-68. PMID: 19052478.
      Citations: 14     Fields:    Translation:Humans
    171. Wang XS, Shi Q, Williams LA, Cleeland CS, Mobley GM, Reuben JM, Lee BN, Giralt SA. Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer. 2008 Oct 15; 113(8):2102-9. PMID: 18792065.
      Citations: 33     Fields:    Translation:Humans
    172. Janjan NA, Cleeland CS. Pain and suffering during cancer therapy: continued sins of omission. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):6-8. PMID: 18722257.
      Citations: 2     Fields:    Translation:Humans
    173. Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad AR, Jay GW, Jermano JA, Katz NP, Manning DC, Martin S, Max MB, McGrath P, McQuay HJ, Quessy S, Rappaport BA, Revicki DA, Rothman M, Stauffer JW, Svensson O, White RE, Witter J. Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials. Pain. 2008 Oct 31; 139(3):485-93. PMID: 18706763.
      Citations: 45     Fields:    Translation:Humans
    174. Westlund KN, Vera-Portocarrero LP, Zhang L, Wei J, Quast MJ, Cleeland CS. fMRI of supraspinal areas after morphine and one week pancreatic inflammation in rats. Neuroimage. 2009 Jan 01; 44(1):23-34. PMID: 18722538.
      Citations: 7     Fields:    Translation:Animals
    175. Armstrong TS, Gning I, Mendoza TR, Weinberg JS, Gilbert MR, Tortorice ML, Cleeland CS. Clinical utility of the MDASI-BT in patients with brain metastases. J Pain Symptom Manage. 2009 Mar; 37(3):331-40. PMID: 18676120.
      Citations: 14     Fields:    Translation:Humans
    176. Shi Q, Wang XS, Mendoza TR, Pandya KJ, Cleeland CS. Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage. 2009 Feb; 37(2):168-74. PMID: 18676116.
      Citations: 14     Fields:    Translation:Humans
    177. Rodgers GM, Becker PS, Bennett CL, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Djulbegovic B, Garst JL, Gilreath JA, Kraut EH, Lin WC, Matulonis U, Millenson M, Reinke D, Rosenthal J, Sabbatini P, Schwartz RN, Stein RS, Vij R. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. 2008 Jul; 6(6):536-64. PMID: 18597709.
      Citations: 8     Fields:    Translation:Humans
    178. Fadol A, Mendoza T, Gning I, Kernicki J, Symes L, Cleeland CS, Lenihan D. Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure. J Card Fail. 2008 Aug; 14(6):497-507. PMID: 18672198.
      Citations: 19     Fields:    Translation:Humans
    179. Rosenthal DI, Mendoza TR, Chambers MS, Burkett VS, Garden AS, Hessell AC, Lewin JS, Ang KK, Kies MS, Gning I, Wang XS, Cleeland CS. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1355-61. PMID: 18501527.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    180. Tseng TH, Cleeland CS, Wang XS, Lin CC. Assessing cancer symptoms in adolescents with cancer using the Taiwanese version of the M. D. Anderson Symptom Inventory. Cancer Nurs. 2008 May-Jun; 31(3):E9-16. PMID: 18453871.
      Citations: 7     Fields:    Translation:Humans
    181. Mystakidou K, Tsilika E, Parpa E, Mendoza TR, Pistevou-Gombaki K, Vlahos L, Cleeland CS. Psychometric properties of the brief fatigue inventory in Greek patients with advanced cancer. J Pain Symptom Manage. 2008 Oct; 36(4):367-73. PMID: 18440770.
      Citations: 8     Fields:    Translation:Humans
    182. Yun YH, Lee MK, Chun HN, Lee YM, Park SM, Mendoza TR, Wang XS, Cleeland CS. Fatigue in the general Korean population: application and normative data of the Brief Fatigue Inventory. J Pain Symptom Manage. 2008 Sep; 36(3):259-67. PMID: 18411013.
      Citations: 12     Fields:    Translation:Humans
    183. Campagnaro E, Saliba R, Giralt S, Roden L, Mendoza F, Aleman A, Cleeland C, Weber D, Brown J, Anderson KO. Symptom burden after autologous stem cell transplantation for multiple myeloma. Cancer. 2008 Apr 01; 112(7):1617-24. PMID: 18260091.
      Citations: 10     Fields:    Translation:Humans
    184. Syrjala KL, Abrams JR, Polissar NL, Hansberry J, Robison J, DuPen S, Stillman M, Fredrickson M, Rivkin S, Feldman E, Gralow J, Rieke JW, Raish RJ, Lee DJ, Cleeland CS, DuPen A. Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial. Pain. 2008 Mar; 135(1-2):175-86. PMID: 18093738.
      Citations: 17     Fields:    Translation:Humans
    185. Torres-Vigil I, Aday LA, Reyes-Gibby C, De Lima L, Herrera AP, Mendoza T, Cleeland CS. Health care providers' assessments of the quality of advanced-cancer care in Latin American medical institutions: a comparison of predictors in five countries: Argentina, Brazil, Cuba, Mexico, and Peru. J Pain Palliat Care Pharmacother. 2008; 22(1):7-20. PMID: 19042817.
      Citations: 5     Fields:    Translation:Humans
    186. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer JW, von Stein T, White RE, Witter J, Zavisic S. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008 Feb; 9(2):105-21. PMID: 18055266.
      Citations: 650     Fields:    Translation:Humans
    187. Efficace F, Novik A, Vignetti M, Mandelli F, Cleeland CS. Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here? Haematologica. 2007 Dec; 92(12):1596-8. PMID: 18055981.
      Citations: 15     Fields:    Translation:Humans
    188. von Gunten CF, Eappen S, Cleary JF, Taylor SG, Moots P, Regevik N, Cleeland C, Cella D. Flecainide for the treatment of chronic neuropathic pain: a Phase II trial. Palliat Med. 2007 Dec; 21(8):667-72. PMID: 18073252.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    189. Kalyadina SA, Ionova TI, Ivanova MO, Uspenskaya OS, Kishtovich AV, Mendoza TR, Guo H, Novik A, Cleeland CS, Wang XS. Russian Brief Pain Inventory: validation and application in cancer pain. J Pain Symptom Manage. 2008 Jan; 35(1):95-102. PMID: 17980999.
      Citations: 17     Fields:    Translation:Humans
    190. Turner RR, Quittner AL, Parasuraman BM, Kallich JD, Cleeland CS. Patient-reported outcomes: instrument development and selection issues. Value Health. 2007 Nov-Dec; 10 Suppl 2:S86-93. PMID: 17995478.
      Citations: 45     Fields:    Translation:Humans
    191. Mock V, Atkinson A, Barsevick AM, Berger AM, Cimprich B, Eisenberger MA, Hinds P, Kaldor P, Otis-Green SA, Piper BF. Cancer-related fatigue. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2007 Nov; 5(10):1054-78. PMID: 18053429.
      Citations: 25     Fields:    Translation:Humans
    192. Turk DC, Dworkin RH, Revicki D, Harding G, Burke LB, Cella D, Cleeland CS, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA. Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain. 2008 Jul 15; 137(2):276-85. PMID: 17937976.
      Citations: 106     Fields:    Translation:Humans
    193. Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, Weber RS, Lewin JS, Garden AS, Ang KK, S Wang X, Cleeland CS. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007 Oct; 29(10):923-31. PMID: 17358040.
      Citations: 51     Fields:    Translation:Humans
    194. Gabrilove JL, Perez EA, Tomita DK, Rossi G, Cleeland CS. Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks. Cancer. 2007 Oct 01; 110(7):1629-40. PMID: 17694552.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    195. Swarm R, Anghelescu DL, Benedetti C, Boston B, Cleeland C, Coyle N, Deleon-Casasola OA, Eidelman A, Eilers JG, Ferrell B, Grossman SA, Janjan NA, Levy MH, Lynch M, Montana GS, Nesbit S, Oakes L, Obbens EA, Paice J, Syrjala KL, Urba S, Weinstein SM. Adult cancer pain. J Natl Compr Canc Netw. 2007 Sep; 5(8):726-51. PMID: 17927930.
      Citations: 4     Fields:    Translation:Humans
    196. Chang EL, Shiu AS, Mendel E, Mathews LA, Mahajan A, Allen PK, Weinberg JS, Brown BW, Wang XS, Woo SY, Cleeland C, Maor MH, Rhines LD. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007 Aug; 7(2):151-60. PMID: 17688054.
      Citations: 111     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    197. Torres Vigil I, Aday LA, De Lima L, Cleeland CS. What predicts the quality of advanced cancer care in Latin America? A look at five countries: Argentina, Brazil, Cuba, Mexico, and Peru. J Pain Symptom Manage. 2007 Sep; 34(3):315-27. PMID: 17616337.
      Citations: 11     Fields:    Translation:Humans
    198. Chang YJ, Lee JS, Lee CG, Lee WS, Lee KS, Bang SM, Wang XS, Mendoza TR, Cleeland CS, Yun YH. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer. 2007 Jul; 15(7):891-6. PMID: 17318593.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    199. Shi Q, Langer G, Cohen J, Cleeland CS. People in pain: how do they seek relief? J Pain. 2007 Aug; 8(8):624-36. PMID: 17586099.
      Citations: 11     Fields:    Translation:Humans
    200. Burkett VS, Cleeland CS. Symptom burden in cancer survivorship. J Cancer Surviv. 2007 Jun; 1(2):167-75. PMID: 18648958.
      Citations: 24     Fields:    Translation:Humans
    201. Portenoy RK, Farrar JT, Backonja MM, Cleeland CS, Yang K, Friedman M, Colucci SV, Richards P. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain. 2007 May; 23(4):287-99. PMID: 17449988.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    202. Anderson KO, Giralt SA, Mendoza TR, Brown JO, Neumann JL, Mobley GM, Wang XS, Cleeland CS. Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant. 2007 Jun; 39(12):759-66. PMID: 17438588.
      Citations: 33     Fields:    Translation:HumansCTClinical Trials
    203. Kwon YC, Yun YH, Lee KH, Son KY, Park SM, Chang YJ, Wang XS, Mendoza TR, Cleeland CS. Symptoms in the lives of terminal cancer patients: which is the most important? Oncology. 2006; 71(1-2):69-76. PMID: 17344672.
      Citations: 8     Fields:    Translation:Humans
    204. Lin CC, Chang AP, Cleeland CS, Mendoza TR, Wang XS. Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients. J Pain Symptom Manage. 2007 Feb; 33(2):180-8. PMID: 17280923.
      Citations: 16     Fields:    Translation:Humans
    205. Cleeland CS. Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr. 2007; (37):16-21. PMID: 17951226.
      Citations: 101     Fields:    Translation:Humans
    206. Jeon YS, Kim HK, Cleeland CS, Wang XS. Clinicians' practice and attitudes toward cancer pain management in Korea. Support Care Cancer. 2007 May; 15(5):463-9. PMID: 17115200.
      Citations: 17     Fields:    Translation:Humans
    207. Palos GR, Cantor SB, Aday LA, Mendoza TR, Mobley GM, Cleeland CS. An urban community's preferences for hypothetical outcomes of analgesic pain treatment. J Pain Symptom Manage. 2006 Nov; 32(5):470-7. PMID: 17085273.
      Citations: 1     Fields:    Translation:Humans
    208. Turk DC, Dworkin RH, Burke LB, Gershon R, Rothman M, Scott J, Allen RR, Atkinson JH, Chandler J, Cleeland C, Cowan P, Dimitrova R, Dionne R, Farrar JT, Haythornthwaite JA, Hertz S, Jadad AR, Jensen MP, Kellstein D, Kerns RD, Manning DC, Martin S, Max MB, McDermott MP, McGrath P, Moulin DE, Nurmikko T, Quessy S, Raja S, Rappaport BA, Rauschkolb C, Robinson JP, Royal MA, Simon L, Stauffer JW, Stucki G, Tollett J, von Stein T, Wallace MS, Wernicke J, White RE, Williams AC, Witter J, Wyrwich KW. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain. 2006 Dec 05; 125(3):208-15. PMID: 17069973.
      Citations: 68     Fields:    Translation:Humans
    209. Lipton A, Berenson JR, Body JJ, Boyce BF, Bruland OS, Carducci MA, Cleeland CS, Clohisy DR, Coleman RE, Cook RJ, Guise TA, Pearse RN, Powles TJ, Rogers MJ, Roodman GD, Smith MR, Suva LJ, Vessella RL, Weilbaecher KN, King L. Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 2):6209s-6212s. PMID: 17062702.
      Citations: 4     Fields:    Translation:Humans
    210. Cleeland CS. The measurement of pain from metastatic bone disease: capturing the patient's experience. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 2):6236s-6242s. PMID: 17062707.
      Citations: 34     Fields:    Translation:Humans
    211. Wang XS, Fairclough DL, Liao Z, Komaki R, Chang JY, Mobley GM, Cleeland CS. Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol. 2006 Sep 20; 24(27):4485-91. PMID: 16983118.
      Citations: 42     Fields:    Translation:Humans
    212. Reyes-Gibby CC, Aday LA, Todd KH, Cleeland CS, Anderson KO. Pain in aging community-dwelling adults in the United States: non-Hispanic whites, non-Hispanic blacks, and Hispanics. J Pain. 2007 Jan; 8(1):75-84. PMID: 16949874.
      Citations: 39     Fields:    Translation:Humans
    213. Hagen NA, Addington-Hall J, Sharpe M, Richardson A, Cleeland CS. The Birmingham International Workshop on Supportive, Palliative, and End-of-Life Care Research. Cancer. 2006 Aug 15; 107(4):874-81. PMID: 16826576.
      Citations: 5     Fields:    Translation:Humans
    214. Reyes-Gibby CC, Aday LA, Anderson KO, Mendoza TR, Cleeland CS. Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage. 2006 Aug; 32(2):118-28. PMID: 16877179.
      Citations: 36     Fields:    Translation:Humans
    215. Lin CC, Chang AP, Chen ML, Cleeland CS, Mendoza TR, Wang XS. Validation of the Taiwanese version of the Brief Fatigue Inventory. J Pain Symptom Manage. 2006 Jul; 32(1):52-9. PMID: 16824985.
      Citations: 12     Fields:    Translation:Humans
    216. Anderson KO, Cohen MZ, Mendoza TR, Guo H, Harle MT, Cleeland CS. Brief cognitive-behavioral audiotape interventions for cancer-related pain: Immediate but not long-term effectiveness. Cancer. 2006 Jul 01; 107(1):207-14. PMID: 16708359.
      Citations: 8     Fields:    Translation:Humans
    217. Shih YC, Wang XS, Cantor SB, Cleeland CS. The association between symptom burdens and utility in Chinese cancer patients. Qual Life Res. 2006 Oct; 15(8):1427-38. PMID: 16791743.
      Citations: 3     Fields:    Translation:Humans
    218. Wang XS, Laudico AV, Guo H, Mendoza TR, Matsuda ML, Yosuico VD, Fragante EP, Cleeland CS. Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage. 2006 Jun; 31(6):542-52. PMID: 16793494.
      Citations: 19     Fields:    Translation:Humans
    219. Reyes-Gibby CC, Ba Duc N, Phi Yen N, Hoai Nga N, Van Tran T, Guo H, Bhat S, Cleeland C. Status of cancer pain in Hanoi, Vietnam: A hospital-wide survey in a tertiary cancer treatment center. J Pain Symptom Manage. 2006 May; 31(5):431-9. PMID: 16716873.
      Citations: 3     Fields:    Translation:Humans
    220. Armstrong TS, Mendoza T, Gning I, Gring I, Coco C, Cohen MZ, Eriksen L, Hsu MA, Gilbert MR, Cleeland C. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol. 2006 Oct; 80(1):27-35. PMID: 16598415.
      Citations: 74     Fields:    Translation:Humans
    221. Yun YH, Mendoza TR, Kang IO, You CH, Roh JW, Lee CG, Lee WS, Lee KS, Bang SM, Park SM, Cleeland CS, Wang XS. Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2006 Apr; 31(4):345-52. PMID: 16632082.
      Citations: 17     Fields:    Translation:Humans
    222. Hindler K, Cleeland CS, Rivera E, Collard CD. The role of statins in cancer therapy. Oncologist. 2006 Mar; 11(3):306-15. PMID: 16549815.
      Citations: 72     Fields:    Translation:Humans
    223. Palos GR, Mendoza TR, Mobley GM, Cantor SB, Cleeland CS. Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain. 2006 Jan; 7(1):49-56. PMID: 16414555.
      Citations: 32     Fields:    Translation:Humans
    224. Rodgers GM, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Demetri GD, Djulbegovic B, Garst JL, Gore M, Kraut EH, Lin WC, Millenson M, Mock V, Reinke D, Rosenthal J, Sabbatini P. Cancer- and treatment-related anemia. J Natl Compr Canc Netw. 2005 Nov; 3(6):772-89. PMID: 16316613.
      Citations: 2     Fields:    Translation:Humans
    225. Ivanova MO, Ionova TI, Kalyadina SA, Uspenskaya OS, Kishtovich AV, Guo H, Mendoza TR, Novik A, Cleeland CS, Wang XS. Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2005 Nov; 30(5):443-53. PMID: 16310618.
      Citations: 22     Fields:    Translation:Humans
    226. Mendoza T, Mayne T, Rublee D, Cleeland C. Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain. 2006 May; 10(4):353-61. PMID: 16051509.
      Citations: 79     Fields:    Translation:Humans
    227. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005 Jun 01; 97(11):798-804. PMID: 15928300.
      Citations: 152     Fields:    Translation:HumansCTClinical Trials
    228. Armstrong TS, Cohen MZ, Eriksen L, Cleeland C. Content validity of self-report measurement instruments: an illustration from the development of the Brain Tumor Module of the M.D. Anderson Symptom Inventory. Oncol Nurs Forum. 2005 May 10; 32(3):669-76. PMID: 15897941.
      Citations: 15     Fields:    Translation:Humans
    229. Cleeland CS, Portenoy RK, Rue M, Mendoza TR, Weller E, Payne R, Kirshner J, Atkins JN, Johnson PA, Marcus A. Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. Ann Oncol. 2005 Jun; 16(6):972-80. PMID: 15821119.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    230. Yun YH, Wang XS, Lee JS, Roh JW, Lee CG, Lee WS, Lee KS, Bang SM, Mendoza TR, Cleeland CS. Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage. 2005 Feb; 29(2):165-72. PMID: 15733808.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    231. Anderson KO, Mendoza TR, Payne R, Valero V, Palos GR, Nazario A, Richman SP, Hurley J, Gning I, Lynch GR, Kalish D, Cleeland CS. Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol. 2004 Dec 15; 22(24):4918-25. PMID: 15611506.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    232. Palos GR, Mendoza TR, Cantor SB, Aday LA, Cleeland CS. Perceptions of analgesic use and side effects: what the public values in pain management. J Pain Symptom Manage. 2004 Nov; 28(5):460-73. PMID: 15504623.
      Citations: 7     Fields:    Translation:Humans
    233. Wang XS, Wang Y, Guo H, Mendoza TR, Hao XS, Cleeland CS. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer. 2004 Oct 15; 101(8):1890-901. PMID: 15386315.
      Citations: 34     Fields:    Translation:Humans
    234. Mendoza TR, Chen C, Brugger A, Hubbard R, Snabes M, Palmer SN, Zhang Q, Cleeland CS. The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trial. Clin J Pain. 2004 Sep-Oct; 20(5):357-62. PMID: 15322443.
      Citations: 37     Fields:    Translation:Humans
    235. Burton AW, Rajagopal A, Shah HN, Mendoza T, Cleeland C, Hassenbusch SJ, Arens JF. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004 Sep; 5(3):239-47. PMID: 15367301.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    236. Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004 Sep-Oct; 20(5):309-18. PMID: 15322437.
      Citations: 263     Fields:    Translation:Humans
    237. Jensen MP, Mendoza T, Hanna DB, Chen C, Cleeland CS. The analgesic effects that underlie patient satisfaction with treatment. Pain. 2004 Jul; 110(1-2):480-7. PMID: 15275801.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    238. Mendoza TR, Chen C, Brugger A, Hubbard R, Snabes M, Palmer SN, Zhang Q, Cleeland CS. Lessons learned from a multiple-dose post-operative analgesic trial. Pain. 2004 May; 109(1-2):103-9. PMID: 15082131.
      Citations: 13     Fields:    Translation:Humans
    239. Wang XS, Hao XS, Wang Y, Guo H, Jiang YQ, Mendoza TR, Cleeland CS. Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). J Pain Symptom Manage. 2004 Apr; 27(4):322-32. PMID: 15050660.
      Citations: 13     Fields:    Translation:Humans
    240. Burton AW, Rajagopal A, Cleeland CS, Hassenbusch SJ, Carr DB. Management of cancer pain. JAMA. 2004 Mar 03; 291(9):1067-8; author reply 1068-9. PMID: 14996772.
      Citations: 1     Fields:    Translation:Humans
    241. Weinstein SM, Romanus D, Lepisto EM, Reyes-Gibby C, Cleeland C, Greene R, Muir C, Niland J. Documentation of pain in comprehensive cancer centers in the United States: a preliminary analysis. J Natl Compr Canc Netw. 2004 Mar; 2(2):173-80. PMID: 19777706.
      Citations: 2     Fields:    Translation:Humans
    242. Pusztai L, Mendoza TR, Reuben JM, Martinez MM, Willey JS, Lara J, Syed A, Fritsche HA, Bruera E, Booser D, Valero V, Arun B, Ibrahim N, Rivera E, Royce M, Cleeland CS, Hortobagyi GN. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine. 2004 Feb 07; 25(3):94-102. PMID: 14698135.
      Citations: 83     Fields:    Translation:HumansCTClinical Trials
    243. Wang XS, Di LJ, Reyes-Gibby CC, Guo H, Liu SJ, Cleeland CS. End-of-life care in urban areas of China: a survey of 60 oncology clinicians. J Pain Symptom Manage. 2004 Feb; 27(2):125-32. PMID: 15157036.
      Citations: 11     Fields:    
    244. Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y. Adequacy of cancer pain management in a Japanese Cancer Hospital. Jpn J Clin Oncol. 2004 Jan; 34(1):37-42. PMID: 15020661.
      Citations: 17     Fields:    Translation:Humans
    245. Mystakidou K, Cleeland C, Tsilika E, Katsouda E, Primikiri A, Parpa E, Vlahos L, Mendoza T. Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patients. Oncology. 2004; 67(3-4):203-10. PMID: 15557779.
      Citations: 13     Fields:    Translation:Humans
    246. Yun YH, Mendoza TR, Heo DS, Yoo T, Heo BY, Park HA, Shin HC, Wang XS, Cleeland CS. Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology. 2004; 66(6):439-44. PMID: 15452372.
      Citations: 33     Fields:    Translation:Humans
    247. Lee BN, Dantzer R, Langley KE, Bennett GJ, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, Wang XS, Cleeland CS. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation. 2004; 11(5):279-92. PMID: 15316238.
      Citations: 87     Fields:    Translation:Humans
    248. Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y. Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage. 2003 Dec; 26(6):1093-104. PMID: 14654261.
      Citations: 39     Fields:    Translation:Humans
    249. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003 Dec; 106(3):337-45. PMID: 14659516.
      Citations: 251     Fields:    Translation:Humans
    250. Reyes-Gibby CC, Mendoza TR, Wang S, Anderson KO, Cleeland CS. Pain and fatigue in community-dwelling adults. Pain Med. 2003 Sep; 4(3):231-7. PMID: 12974822.
      Citations: 9     Fields:    Translation:Humans
    251. Cleeland CS, Reyes-Gibby CC, Schall M, Nolan K, Paice J, Rosenberg JM, Tollett JH, Kerns RD. Rapid improvement in pain management: the Veterans Health Administration and the institute for healthcare improvement collaborative. Clin J Pain. 2003 Sep-Oct; 19(5):298-305. PMID: 12966255.
      Citations: 22     Fields:    Translation:Humans
    252. Wang XS, Tang JY, Zhao M, Guo H, Mendoza T, Cleeland CS. Pediatric cancer pain management practices and attitudes in China. J Pain Symptom Manage. 2003 Aug; 26(2):748-59. PMID: 12906960.
      Citations: 4     Fields:    Translation:Humans
    253. Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, Wang XS, Lee BN. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer. 2003 Jun 01; 97(11):2919-25. PMID: 12767108.
      Citations: 151     Fields:    Translation:HumansAnimals
    254. Reyes-Gibby CC, McCrory LL, Cleeland CS. Variations in patients' self-report of pain by treatment setting. J Pain Symptom Manage. 2003 May; 25(5):444-8. PMID: 12727042.
      Citations: 8     Fields:    Translation:Humans
    255. Radbruch L, Sabatowski R, Elsner F, Everts J, Mendoza T, Cleeland C. Validation of the German version of the brief fatigue inventory. J Pain Symptom Manage. 2003 May; 25(5):449-58. PMID: 12727043.
      Citations: 21     Fields:    Translation:Humans
    256. Anderson KO, Getto CJ, Mendoza TR, Palmer SN, Wang XS, Reyes-Gibby CC, Cleeland CS. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage. 2003 Apr; 25(4):307-18. PMID: 12691682.
      Citations: 40     Fields:    Translation:Humans
    257. Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y. Validation study of the Japanese version of the brief fatigue inventory. J Pain Symptom Manage. 2003 Feb; 25(2):106-17. PMID: 12590026.
      Citations: 15     Fields:    Translation:Humans
    258. Badia X, Muriel C, Gracia A, Núñez-Olarte JM, Perulero N, Gálvez R, Carulla J, Cleeland CS. [Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain]. Med Clin (Barc). 2003 Jan 25; 120(2):52-9. PMID: 12570914.
      Citations: 33     Fields:    Translation:HumansCTClinical Trials
    259. Klepstad P, Loge JH, Borchgrevink PC, Mendoza TR, Cleeland CS, Kaasa S. The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage. 2002 Nov; 24(5):517-25. PMID: 12547051.
      Citations: 60     Fields:    Translation:Humans
    260. Esnaola NF, Cantor SB, Johnson ML, Mirza AN, Miller AR, Curley SA, Crane CH, Cleeland CS, Janjan NA, Skibber JM. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol. 2002 Nov 01; 20(21):4361-7. PMID: 12409336.
      Citations: 15     Fields:    Translation:Humans
    261. Cleeland CS, Reyes-Gibby CC. When is it justified to treat symptoms? Measuring symptom burden. Oncology (Williston Park). 2002 Sep; 16(9 Suppl 10):64-70. PMID: 12380956.
      Citations: 19     Fields:    Translation:Humans
    262. Crawford J, Cella D, Cleeland CS, Cremieux PY, Demetri GD, Sarokhan BJ, Slavin MB, Glaspy JA. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer. 2002 Aug 15; 95(4):888-95. PMID: 12209734.
      Citations: 59     Fields:    Translation:HumansCTClinical Trials
    263. Anderson KO, Richman SP, Hurley J, Palos G, Valero V, Mendoza TR, Gning I, Cleeland CS. Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer. 2002 Apr 15; 94(8):2295-304. PMID: 12001130.
      Citations: 43     Fields:    Translation:Humans
    264. Wang XS, Giralt SA, Mendoza TR, Engstrom MC, Johnson BA, Peterson N, Broemeling LD, Cleeland CS. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol. 2002 Mar 01; 20(5):1319-28. PMID: 11870175.
      Citations: 21     Fields:    Translation:Humans
    265. Cleeland CS. Pain assessment: the advantages of using pain scales in lysosomal storage diseases. Acta Paediatr Suppl. 2002; 91(439):43-7. PMID: 12572842.
      Citations: 8     Fields:    Translation:Humans
    266. Reyes-Gibby CC, Aday L, Cleeland C. Impact of pain on self-rated health in the community-dwelling older adults. Pain. 2002 Jan; 95(1-2):75-82. PMID: 11790469.
      Citations: 44     Fields:    Translation:Humans
    267. Escalante CP, Grover T, Johnson BA, Harle M, Guo H, Mendoza TR, Rivera E, Ho V, Lee EL, Cleeland CS. A fatigue clinic in a comprehensive cancer center: design and experiences. Cancer. 2001 Sep 15; 92(6 Suppl):1708-13. PMID: 11598891.
      Citations: 4     Fields:    Translation:Humans
    268. Wang XS, Janjan NA, Guo H, Johnson BA, Engstrom MC, Crane CH, Mendoza TR, Cleeland CS. Fatigue during preoperative chemoradiation for resectable rectal cancer. Cancer. 2001 Sep 15; 92(6 Suppl):1725-32. PMID: 11598894.
      Citations: 10     Fields:    Translation:Humans
    269. Cleeland CS. Cancer-related fatigue: new directions for research. Introduction. Cancer. 2001 Sep 15; 92(6 Suppl):1657-61. PMID: 11598882.
      Citations: 5     Fields:    Translation:Humans
    270. Burton AW, Cleeland CS. Cancer pain: progress since the WHO guidelines. Pain Pract. 2001 Sep; 1(3):236-42. PMID: 17134407.
      Citations: 6     Fields:    
    271. Guo H, Fine PG, Mendoza TR, Cleeland CS. A preliminary study of the utility of the brief hospice inventory. J Pain Symptom Manage. 2001 Aug; 22(2):637-48. PMID: 11495710.
      Citations: 5     Fields:    Translation:Humans
    272. Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol. 2001 Jun 01; 19(11):2875-82. PMID: 11387360.
      Citations: 76     Fields:    Translation:HumansCTClinical Trials
    273. Mystakidou K, Mendoza T, Tsilika E, Befon S, Parpa E, Bellos G, Vlahos L, Cleeland C. Greek brief pain inventory: validation and utility in cancer pain. Oncology. 2001; 60(1):35-42. PMID: 11150906.
      Citations: 18     Fields:    Translation:Humans
    274. Yu S, Wang XS, Cheng Y, Yang J, Cleeland CS. Special aspects of cancer pain management in a Chinese general hospital. Eur J Pain. 2001; 5 Suppl A:15-20. PMID: 11798212.
      Citations: 12     Fields:    Translation:Humans
    275. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberger MA, Escalante C, Hinds P, Jacobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C. NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park). 2000 Nov; 14(11A):151-61. PMID: 11195408.
      Citations: 95     Fields:    Translation:Humans
    276. Benedetti C, Brock C, Cleeland C, Coyle N, Dubé JE, Ferrell B, Hassenbusch S, Janjan NA, Lema MJ, Levy MH, Loscalzo MJ, Lynch M, Muir C, Oakes L, O'Neill A, Payne R, Syrjala KL, Urba S, Weinstein SM. NCCN Practice Guidelines for Cancer Pain. Oncology (Williston Park). 2000 Nov; 14(11A):135-50. PMID: 11195407.
      Citations: 27     Fields:    Translation:Humans
    277. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000 Oct 01; 89(7):1634-46. PMID: 11013380.
      Citations: 354     Fields:    Translation:Humans
    278. Cleeland CS. Cancer-related symptoms. Semin Radiat Oncol. 2000 Jul; 10(3):175-90. PMID: 11034629.
      Citations: 23     Fields:    Translation:Humans
    279. Anderson KO, Mendoza TR, Valero V, Richman SP, Russell C, Hurley J, DeLeon C, Washington P, Palos G, Payne R, Cleeland CS. Minority cancer patients and their providers: pain management attitudes and practice. Cancer. 2000 Apr 15; 88(8):1929-38. PMID: 10760771.
      Citations: 76     Fields:    Translation:Humans
    280. Cleeland CS, Janjan NA, Scott CB, Seiferheld WF, Curran WJ. Cancer pain management by radiotherapists: a survey of radiation therapy oncology group physicians. Int J Radiat Oncol Biol Phys. 2000 Apr 01; 47(1):203-8. PMID: 10758325.
      Citations: 21     Fields:    Translation:Humans
    281. Wang XS, Cleeland CS, Mendoza TR, Engstrom MC, Liu S, Xu G, Hao X, Wang Y, Ren XS. The effects of pain severity on health-related quality of life: a study of Chinese cancer patients. Cancer. 1999 Nov 01; 86(9):1848-55. PMID: 10547560.
      Citations: 25     Fields:    Translation:Humans
    282. Ger LP, Ho ST, Sun WZ, Wang MS, Cleeland CS. Validation of the Brief Pain Inventory in a Taiwanese population. J Pain Symptom Manage. 1999 Nov; 18(5):316-22. PMID: 10584454.
      Citations: 27     Fields:    Translation:Humans
    283. Radbruch L, Loick G, Kiencke P, Lindena G, Sabatowski R, Grond S, Lehmann KA, Cleeland CS. Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage. 1999 Sep; 18(3):180-7. PMID: 10517039.
      Citations: 57     Fields:    Translation:HumansCTClinical Trials
    284. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999 Mar 01; 85(5):1186-96. PMID: 10091805.
      Citations: 432     Fields:    Translation:Humans
    285. Saxena A, Mendoza T, Cleeland CS. The assessment of cancer pain in north India: the validation of the Hindi Brief Pain Inventory--BPI-H. J Pain Symptom Manage. 1999 Jan; 17(1):27-41. PMID: 9919863.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    286. Uki J, Mendoza T, Cleeland CS, Nakamura Y, Takeda F. A brief cancer pain assessment tool in Japanese: the utility of the Japanese Brief Pain Inventory--BPI-J. J Pain Symptom Manage. 1998 Dec; 16(6):364-73. PMID: 9879161.
      Citations: 46     Fields:    Translation:HumansCTClinical Trials
    287. Cleeland CS. Undertreatment of cancer pain in elderly patients. JAMA. 1998 Jun 17; 279(23):1914-5. PMID: 9634265.
      Citations: 21     Fields:    Translation:Humans
    288. Mercadante S. Comments on Wang et al., PAIN, 67 (1996) 407-416. Pain. 1998 Jan; 74(1):106-7. PMID: 9514568.
      Citations: 3     Fields:    Translation:Humans
    289. Janjan NA, Cleeland C, Payne R. World Conference for Cancer Organisations March 3-7, 1996, Melbourne, Australia. Cancer. 1998 Jan 01; 82(1):234-5. PMID: 9428506.
      Citations:    Fields:    Translation:Humans
    290. Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ. Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med. 1997 Nov 01; 127(9):813-6. PMID: 9382402.
      Citations: 98     Fields:    Translation:Humans
    291. Brady A, Cleeland C, Goldstein G, Lefkowitz M, Linden-Malek P, Martens G, Miller SJ, Portenoy RK, Simmonds MA. Pain management guidelines: implications for managed care--a roundtable discussion. Med Interface. 1997; Suppl:10-32. PMID: 10164785.
      Citations:    Fields:    Translation:Humans
    292. Cleeland CS, Nakamura Y, Mendoza TR, Edwards KR, Douglas J, Serlin RC. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain. 1996 Oct; 67(2-3):267-73. PMID: 8951920.
      Citations: 58     Fields:    Translation:Humans
    293. Wang XS, Mendoza TR, Gao SZ, Cleeland CS. The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain. Pain. 1996 Oct; 67(2-3):407-16. PMID: 8951936.
      Citations: 39     Fields:    Translation:Humans
    294. Cleeland CS, Nakamura Y, Howland EW, Morgan NR, Edwards KR, Backonja M. Effects of oral morphine on cold pressor tolerance time and neuropsychological performance. Neuropsychopharmacology. 1996 Sep; 15(3):252-62. PMID: 8873108.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    295. Zhang H, Gu WP, Joranson DE, Cleeland C. People's Republic of China: status of cancer pain and palliative care. J Pain Symptom Manage. 1996 Aug; 12(2):124-6. PMID: 8754998.
      Citations: 2     Fields:    Translation:Humans
    296. Caraceni A, Mendoza TR, Mencaglia E, Baratella C, Edwards K, Forjaz MJ, Martini C, Serlin RC, de Conno F, Cleeland CS. A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain. 1996 Apr; 65(1):87-92. PMID: 8826494.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    297. Rice D, Cleeland C. [Problems in organization and management of Russian public health in the XXI century: style, strategy, system]. Probl Sotsialnoi Gig Istor Med. 1996 Mar-Apr; (2):36-41. PMID: 9289339.
      Citations:    Fields:    
    298. Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA. 1995 Dec 20; 274(23):1874-80. PMID: 7500539.
      Citations: 81     Fields:    Translation:Humans
    299. Howland EW, Wakai RT, Mjaanes BA, Balog JP, Cleeland CS. Whole head mapping of magnetic fields following painful electric finger shock. Brain Res Cogn Brain Res. 1995 Jul; 2(3):165-72. PMID: 7580398.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    300. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995 May; 61(2):277-84. PMID: 7659438.
      Citations: 294     Fields:    Translation:Humans
    301. Larue F, Colleau SM, Brasseur L, Cleeland CS. Multicentre study of cancer pain and its treatment in France. BMJ. 1995 Apr 22; 310(6986):1034-7. PMID: 7728056.
      Citations: 48     Fields:    Translation:Humans
    302. Love RR, Cleeland CS, Sherman CD. The role of the American Society of Clinical Oncology in cancer control worldwide. J Clin Oncol. 1995 Jan; 13(1):300. PMID: 7799034.
      Citations:    Fields:    Translation:Humans
    303. Karnad AB. Treating cancer pain. N Engl J Med. 1994 Jul 21; 331(3):199; author reply 201. PMID: 7516494.
      Citations:    Fields:    Translation:Humans
    304. Management of cancer pain: adults. Cancer Pain Guideline Panel. Agency for Health Care Policy and Research. Am Fam Physician. 1994 Jun; 49(8):1853-68. PMID: 8203323.
      Citations: 4     Fields:    Translation:Humans
    305. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994 Mar 03; 330(9):592-6. PMID: 7508092.
      Citations: 320     Fields:    Translation:Humans
    306. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994 Mar; 23(2):129-38. PMID: 8080219.
      Citations:    
    307. Cleeland CS. Strategies for improving cancer pain management. J Pain Symptom Manage. 1993 Aug; 8(6):361-4. PMID: 7525751.
      Citations: 3     Fields:    Translation:Humans
    308. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993 Jul 15; 119(2):121-6. PMID: 8099769.
      Citations: 106     Fields:    Translation:Humans
    309. Dar R, Beach CM, Barden PL, Cleeland CS. Cancer pain in the marital system: a study of patients and their spouses. J Pain Symptom Manage. 1992 Feb; 7(2):87-93. PMID: 1573290.
      Citations: 13     Fields:    Translation:Humans
    310. Backonja M, Howland EW, Wang J, Smith J, Salinsky M, Cleeland CS. Tonic changes in alpha power during immersion of the hand in cold water. Electroencephalogr Clin Neurophysiol. 1991 Sep; 79(3):192-203. PMID: 1714810.
      Citations: 15     Fields:    Translation:Humans
    311. Zelman DC, Howland EW, Nichols SN, Cleeland CS. The effects of induced mood on laboratory pain. Pain. 1991 Jul; 46(1):105-11. PMID: 1896201.
      Citations: 27     Fields:    Translation:Humans
    312. Cleeland C. Research in cancer pain. What we know and what we need to know. Cancer. 1991 Feb 01; 67(3 Suppl):823-7. PMID: 1986852.
      Citations: 21     Fields:    Translation:Humans
    313. Redd WH, Silberfarb PM, Andersen BL, Andrykowski MA, Bovbjerg DH, Burish TG, Carpenter PJ, Cleeland C, Dolgin M, Levy SM, et al. Physiologic and psychobehavioral research in oncology. Cancer. 1991 Feb 01; 67(3 Suppl):813-22. PMID: 1986851.
      Citations: 6     Fields:    Translation:Humans
    314. Joseph J, Howland EW, Wakai R, Backonja M, Baffa O, Potenti FM, Cleeland CS. Late pain-related magnetic fields and electric potentials evoked by intracutaneous electric finger stimulation. Electroencephalogr Clin Neurophysiol. 1991 Jan-Feb; 80(1):46-52. PMID: 1703949.
      Citations:    Fields:    Translation:Humans
    315. McGrath PJ, Beyer J, Cleeland C, Eland J, McGrath PA, Portenoy R. American Academy of Pediatrics Report of the Subcommittee on Assessment and Methodologic Issues in the Management of Pain in Childhood Cancer. Pediatrics. 1990 Nov; 86(5 Pt 2):814-7. PMID: 2216643.
      Citations: 9     Fields:    Translation:Humans
    316. Tearnan BH, Cleeland CS. Unaided use of pain descriptors by patients with cancer pain. J Pain Symptom Manage. 1990 Aug; 5(4):228-32. PMID: 2384702.
      Citations:    Fields:    Translation:Humans
    317. Hodes RL, Howland EW, Lightfoot N, Cleeland CS. The effects of distraction on responses to cold pressor pain. Pain. 1990 Apr; 41(1):109-14. PMID: 2352758.
      Citations: 9     Fields:    Translation:Humans
    318. Cleeland CS. Clinical cancer: 31. Barriers to the management of cancer pain: the roles of patient and family. Wis Med J. 1988 Nov; 87(11):13-5. PMID: 2466376.
      Citations:    Fields:    Translation:Humans
    319. Cleeland CS, Ladinsky JL, Serlin RC, Nugyen CT. Multidimensional measurement of cancer pain: comparisons of US and Vietnamese patients. J Pain Symptom Manage. 1988; 3(1):23-7. PMID: 3351345.
      Citations: 12     Fields:    Translation:Humans
    320. Cleeland CS. Barriers to the management of cancer pain. Oncology (Williston Park). 1987 Apr; 1(2 Suppl):19-26. PMID: 2484445.
      Citations: 7     Fields:    Translation:Humans
    321. Cleeland CS. Nonpharmacological management of cancer pain. J Pain Symptom Manage. 1987; 2(2):S23-8. PMID: 3647079.
      Citations: 2     Fields:    Translation:Humans
    322. Cleeland CS, Cleeland LM, Dar R, Rinehardt LC. Factors influencing physician management of cancer pain. Cancer. 1986 Aug 01; 58(3):796-800. PMID: 2873882.
      Citations: 14     Fields:    Translation:Humans
    323. Cleeland CS, Rotondi A, Brechner T, Levin A, MacDonald N, Portenoy R, Schutta H, McEniry M. A model for the treatment of cancer pain. J Pain Symptom Manage. 1986; 1(4):209-15. PMID: 3640794.
      Citations: 2     Fields:    Translation:Humans
    324. Cleeland CS. How to treat a "construct". J Pain Symptom Manage. 1986; 1(3):161-2. PMID: 3639916.
      Citations: 2     Fields:    Translation:Humans
    325. Cleeland CS. Behavioral control of symptoms--introduction. J Pain Symptom Manage. 1986; 1(1):36-8. PMID: 3633302.
      Citations:    Fields:    Translation:Humans
    326. Levin DN, Cleeland CS, Dar R. Public attitudes toward cancer pain. Cancer. 1985 Nov 01; 56(9):2337-9. PMID: 2865000.
      Citations: 15     Fields:    Translation:Humans
    327. Cleeland CS. Measurement and prevalence of pain in cancer. Semin Oncol Nurs. 1985 May; 1(2):87-92. PMID: 3849841.
      Citations: 22     Fields:    Translation:Humans
    328. Yocum DE, Hodes R, Sundstrom WR, Cleeland CS. Use of biofeedback training in treatment of Raynaud's disease and phenomenon. J Rheumatol. 1985 Feb; 12(1):90-3. PMID: 3981523.
      Citations: 4     Fields:    Translation:Humans
    329. Cleeland CS. The impact of pain on the patient with cancer. Cancer. 1984 Dec 01; 54(11 Suppl):2635-41. PMID: 6498754.
      Citations: 22     Fields:    Translation:Humans
    330. Montgomery GK, Howland EW, Cleeland CS, Mueller WC, Dearing MP. Versatility in computer automation for biofeedback: the behavioral assessment and rehabilitative training system (BARTS). Biofeedback Self Regul. 1984 Sep; 9(3):325-37. PMID: 6549265.
      Citations: 1     Fields:    Translation:Humans
    331. Cleeland CS, Shacham S, Dahl JL, Orrison W. CSF beta-endorphin and the severity of pain. Neurology. 1984 Mar; 34(3):378-80. PMID: 6322046.
      Citations: 4     Fields:    Translation:Humans
    332. Shacham S, Dar R, Cleeland CS. The relationship of mood state to the severity of clinical pain. Pain. 1984 Feb; 18(2):187-97. PMID: 6709386.
      Citations: 4     Fields:    Translation:Humans
    333. Shacham S, Reinhardt LC, Raubertas RF, Cleeland CS. Emotional states and pain: intraindividual and interindividual measures of association. J Behav Med. 1983 Dec; 6(4):405-19. PMID: 6668606.
      Citations: 3     Fields:    Translation:Humans
    334. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983 Oct; 17(2):197-210. PMID: 6646795.
      Citations: 293     Fields:    Translation:Humans
    335. Teske K, Daut RL, Cleeland CS. Relationships between nurses' observations and patients' self-reports of pain. Pain. 1983 Jul; 16(3):289-96. PMID: 6888955.
      Citations: 9     Fields:    Translation:Humans
    336. Zimmermann G, Liljeblad S, Frank A, Cleeland C. The Indians have many terms for it: stuttering among the Bannock-Shoshoni. J Speech Hear Res. 1983 Jun; 26(2):315-8. PMID: 6350705.
      Citations: 2     Fields:    Translation:Humans
    337. Daut RL, Cleeland CS. The prevalence and severity of pain in cancer. Cancer. 1982 Nov 01; 50(9):1913-8. PMID: 7116316.
      Citations: 65     Fields:    Translation:Humans
    338. Cleeland C. Pain and its severity in cancer patients. PRN Forum. 1982 Apr-May; 1(2):1-2. PMID: 6924389.
      Citations: 2     Fields:    Translation:Humans
    339. Wear JB, Wear RB, Cleeland C. Biofeedback in urology using urodynamics: preliminary observations. J Urol. 1979 Apr; 121(4):464-8. PMID: 439220.
      Citations: 3     Fields:    Translation:Humans
    340. Harley JP, Ray RS, Tomasi L, Eichman PL, Matthews CG, Chun R, Cleeland CS, Traisman E. Hyperkinesis and food additives: testing the Feingold hypothesis. Pediatrics. 1978 Jun; 61(6):818-28. PMID: 353681.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    341. Quaglieri CE, Chun RW, Cleeland C. Movement disorders as a complication of acute hemiplegia of childhood. Am J Dis Child. 1977 Sep; 131(9):1009-10. PMID: 900077.
      Citations: 2     Fields:    Translation:Humans
    342. Haaland KY, Cleeland CS, Carr D. Motor performance after unilateral hemisphere damage in patients with tumor. Arch Neurol. 1977 Sep; 34(9):556-9. PMID: 889498.
      Citations: 7     Fields:    Translation:Humans
    343. Cleeland CS. Behavioral technics in the modification of spasmodic torticollis. Neurology. 1973 Nov; 23(11):1241-7. PMID: 4795741.
      Citations: 12     Fields:    Translation:Humans
    344. Netsell R, Cleeland CS. Modification of lip hypertonia in dysarthria using EMG feedback. J Speech Hear Disord. 1973 Feb; 38(1):131-40. PMID: 4698381.
      Citations: 6     Fields:    Translation:Humans
    345. Hopper CL, Matthews CG, Cleeland CS. Symptom instability and thermoregulation in multiple sclerosis. Neurology. 1972 Feb; 22(2):142-8. PMID: 5061845.
      Citations: 5     Fields:    Translation:Humans
    346. Klove H, Cleeland CS. The relationship of neuropsychological impairment to other indices of severity of head injury. Scand J Rehabil Med. 1972; 4(2):55-60. PMID: 4645036.
      Citations: 8     Fields:    Translation:Humans
    347. Graebner RW, Cleeland CS. Neurological and neuropsychological effects of botulinum toxin. Dis Nerv Syst. 1971 Oct; 32(10):702-6. PMID: 4401697.
      Citations: 1     Fields:    Translation:Humans
    348. Cleeland CS, Matthews CG, Hopper CL. MMPI profiles in exacerbation and remission of multiple sclerosis. Psychol Rep. 1970 Oct; 27(2):373-4. PMID: 4394977.
      Citations:    Fields:    Translation:Humans
    349. Booker HE, Cleeland CS. Sustained sensory input and epileptiform activity. Dis Nerv Syst. 1970 Apr; 31(4):265-8. PMID: 4987152.
      Citations:    Fields:    Translation:HumansPHPublic Health
    350. Matthews CG, Cleeland CS, Hopper CL. Neuropsychological patterns in multiple sclerosis. Dis Nerv Syst. 1970 Mar; 31(3):161-70. PMID: 4392525.
      Citations: 5     Fields:    Translation:Humans
    351. Forster FM, Hansotia P, Cleeland CS, Ludwig A. A case of voice-induced epilepsy treated by conditioning. Neurology. 1969 Apr; 19(4):325-31. PMID: 4975834.
      Citations:    Fields:    Translation:Humans
    352. Forster FM, Cleeland CS. Somatosensory evoked epilepsy. Trans Am Neurol Assoc. 1969; 94:268-9. PMID: 5374457.
      Citations:    Fields:    Translation:Humans
    353. Forster FM, Hansotia P, Cleeland CS, Ludwig A. A case of voice-induced epilepsy by conditioning. Neurology. 1968 Mar; 18(3):290. PMID: 5690371.
      Citations:    Fields:    Translation:Humans
    354. Hansotia P, Cleeland CS, Chun RW. Juvenile Huntington's chorea. Neurology. 1968 Mar; 18(3):217-24. PMID: 4231060.
      Citations: 6     Fields:    Translation:Humans
    355. Cleeland CS, Booker HE. Petit mal evoked by arousal during sensory restriction. Arch Neurol. 1967 Sep; 17(3):324-30. PMID: 4964098.
      Citations:    Fields:    Translation:Humans
    356. SINES JO, ADKINS J, CLEELAND C. THE CONTROL OF BEHAVIOR OUTPUT AS RELATED TO THE CONCEPT OF ACTIVATION. J Genet Psychol. 1964 Mar; 104:99-104. PMID: 14128968.
      Citations:    Fields:    Translation:HumansAnimals
    357. Working after a metastatic cancer diagnosis. Cancer.
    358. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials. The Lancet Oncology. 17:e510-e514.
    359. Erratum. Quality of Life Research. 20:151-152.
    360. The Added Value of Analyzing Pooled Health-Related Quality of Life Data. Journal of the National Cancer Institute. 108.
    361. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Quality of Life Research. 1-9.
    362. Quick reference guide for clinicians management of cancer pain. Journal of Pharmaceutical Care in Pain and Symptom Control. 2:47-73.
    363. Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer. Supportive Care in Cancer. 1-9.
    364. Properties of the measures to assess oxaliplatin-induced peripheral neuropathy. Journal of Korean Academy of Nursing. 45:783-801.
    365. Management of Cancer Pain [3] (multiple letters). Journal of the American Medical Association. 291:1067-1069.
    366. Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Supportive Care in Cancer. 24:1327-1337.
    367. Issues in the management of bone metastases. Current Oncology. 9:42-47.
    368. Assessing symptom burden in breast cancer patients treated with darbepoetin alfa 200 μg every two weeks using the M.D. Anderson Symptom Inventory. Journal of Supportive Oncology. 3:34-35.
    369. Patient-Reported Outcomes Accurately Measure the Value of an Enhanced Recovery Program in Liver Surgery Poster abstract presented at the 123rd Annual Western Surgical Association Meeting, Napa Valley, CA, November 2015. Journal of the American College of Surgeons. 221:1023-1030.e2.
    370. Reply to H. Charalambous et al. Journal of Clinical Oncology. 30:4043.
    371. Linguistic validation of the Greek M.D. ANderson Symptom Inventory - Head and Neck Module. Forum of Clinical Oncology. 3:29-31.
    372. Symptom recovery after thoracic surgery. Journal of Thoracic and Cardiovascular Surgery. 150:613-619e2.
    373. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language. Journal of Pain and Symptom Management.
    374. Reply to symptom burden in cancer survivors 1 year after diagnosis. Cancer. 118:1955-1956.
    375. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa. Radiotherapy and Oncology. 117:132-138.
    376. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials. Cancer. 122:3401-3409.
    377. Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia. The Lancet Haematology.
    378. Commentary. Acta Paediatrica, International Journal of Paediatrics, Supplement. 91:33.
    379. Quick reference guide for clinicians management of cancer pain. Journal of Pharmaceutical Care in Pain and Symptom Control. 2:75-103.
    380. Mechanisms of treatment-related symptoms in cancer patients. European Journal of Cancer, Supplement. 11:301-302.
    381. Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma. Leukemia and Lymphoma. 56:1335-1341.
    382. Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer. Oncology (Switzerland).
    383. Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancer. European Journal of Cancer. 67:83-90.
    384. Linguistic validation of the Turkish version of the M.D. Anderson symptom inventory - Head and neck cancer module. Balkan Medical Journal. 33:339-343.
    385. Treating cancer symptoms improves quality of life. Part II. International Journal of Pharmaceutical Medicine. 14:92-94.
    386. Enhancing quality of life as a goal for anticancer therapeutics. Science Translational Medicine. 8.
    387. Erratum. Journal of Neuro-Oncology. 80:37.
    388. Discussion of issues concerning the quality of life in cancer patients. International Journal of Pharmaceutical Medicine. 14:95-97.
    389. Measuring and understanding fatigue. Oncology. 13:91-97.
    390. Patient-Reported Symptom Interference as a Measure of Postsurgery Functional Recovery in Lung Cancer. Journal of Pain and Symptom Management. 52:822-831.
    391. Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer. International Journal of Radiation Oncology Biology Physics. 95:1107-1114.
    392. Cancer pain. Journal of Pharmaceutical Care in Pain and Symptom Control. 5:5-16.
    393. Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy. Journal of Pain and Symptom Management.
    394. Erratum to. Supportive Care in Cancer. 22:2309-2310.
    395. Measuring Therapy-Induced Peripheral Neuropathy. Journal of Pain. 16:1032-1043.
    396. Moving beyond 'Best supportive care'. Oncology. 25.
    397. Efficacy of the natural clay, calcium aluminosilicate anti-diarrheal, in reducing medullary thyroid cancer-related diarrhea and its effects on quality of life. Thyroid. 25:1085-1090.
    398. The behavior of normal and stomach lesion susceptible rats in several learning situations. The Journal of genetic psychology. 102:91-94.
    399. Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis. Biology of Blood and Marrow Transplantation. 22:226-231.
    400. Validity and Reliability of the Indonesian Version of the Brief Fatigue Inventory in Cancer Patients. Journal of Pain and Symptom Management. 52:744-751.
    401. From the JAMA Web Sites. JAMA - Journal of the American Medical Association. 278:955.
    CLEELAND's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (765)
    Explore
    _
    Co-Authors (143)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _